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SUMMARY.
Interferons (IFNs) are a class of regulatory cytokines capable of inducing 
a non-specific antiviral activity in target cells. Under normal conditions the 
synthesis of IFN is not usually detectable, but following exposure of cells to 
inducers such as virus or double stranded RNA, IFN is produced in large 
amounts. Expression of the IFN genes is tissue specific and comes about 
by the activation of transcription. Cis-acting virus responsive elements 
(VREs) responsible for transcriptional activation have been identified within 
the 5'-flanking sequences of the human IFN-a1 and -(3 genes and show 
considerable sequence similarity.
Although HeLa cells express IFN-p mRNA and protein following 
induction, no IFN-a transcripts are detectable. The tissue specific 
expression of the IFN genes in Hela cells was investigated by determining 
whether a hybrid reporter gene under the control of the virus responsive 
element of the human IFN-a1 gene (VREal) was inducible. Evidence was 
obtained indicating that although the endogenous IFN-a1 gene is not 
expressed following virus induction, the reporter gene is. Consequently, it 
appears that the endogenous IFN-a1 gene in Hela cells is subject to some 
form of negative repression which the plasmid borne reporter gene is able 
to evade.
Tetramers of GAAAGT and AAGTGA, motifs present in the VREs of the 
IFN-a1 and -p genes respectively, have been shown to confer virus 
inducibility upon a heterologous promoter. Sequences of the type GAAANN 
are particularly frequent in the promoters of IFN and IFN-inducible genes 
and have been postulated to play a role in the induction of these genes. 
Tetramers of all such sequences present in VREal and in the promoter of 
the murine Mx gene were examined with regard to their inducibility when 
assayed in conjunction with a minimal promoter.
Three distinct types of hexamers were distinguished, all of which 
mediated virus inducibility, but differed in other respects. Type I 
oligonucleotides (NN= GT, GC, CT and CC) respond to IFNs, cause 
silencing and are transactivated by interferon regulatory factor-1 (IRF-1). 
Type II (NN= TG) and type III (NN= CG) oligonucleotides which neither 
respond to IFN or IRF-1 and do not silence were distinguished by the
criterion that only the type III oligonucleotide mediates constitutive 
transcription.
Using gel retardation analysis, the interaction of nuclear proteins with the 
tetrameric hexanucleotides was investigated. Such analysis revealed that 
the three types of oligonucleotide bind different nuclear proteins. Type I 
oligonucleotides all interact with the same proteins, which were competed 
by VREp but by no other oligonucleotide tested. The type II oligonucleotide, 
GAAATG on the other hand has an affinity for different nuclear factors that 
also interact with the VREal. One of these proteins was identified as the 
ubiquitous octamer factor OTF-1, while another was a novel protein, which 
while having affinity for both (GAAATG)4 and VREal showed no affinity to 
any other element tested. This novel protein which interacts with VREal 
and (GAAATG)4 at their common sequence GAAATGGAAA (TG 
sequence'), was designated 'TG protein' and is a possible candidate for 
mediating the virus inducibility of these two elements, neither of which are 
transactivated by IRF-1.
Thus it appears that despite their similarity, the VRE elements of the 
IFN-a1 and -p genes contain different response elements which mediate 
their virus inducibility. The work of others has indicated that the IFN-p 
promoter uses at least two distinct virus responsive elements, a type l-like 
sequence (PRDI) and an NF-KB-binding sequence (PRDII). The IFN-a1 
gene on the other hand uses a novel virus responsive element, the 'TG 
sequence' which is distinct from both PRDI and PRDII and may mediate 
virus inducibility through its interaction with the 'TG protein'. Thus, type I, 
type II and NF-kB elements represent three distinct terminal pathways 
mediating virus induction of the IFN genes.
v
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1. INTRODUCTION.
1.1 Viral Interference.
Viral interference, the ability of one virus to interfere with the replication 
of another, was first described in 1935 by Hoskins, who showed that 
monkeys infected with a neurotropic strain of yellow fever virus were 
protected against a viscerotropic strain of the same virus. Two years later, 
viral interference was shown to be a general phenomenon even occurring 
between immunologically unrelated viruses (Findlay and MacCullum, 
1937) and in the absence of viral replication (reviewed in Schleringer, 
1959).
1.2 Discovery of Interferon.
It was not until 1957 that Isaacs and Lindenmann discovered a molecule 
that mediated viral interference, which they termed interferon (IFN). In brief, 
they incubated heat-inactivated influenza virus with chicken chorioallantoic 
membrane and showed that the supernatant inhibited the replication of live 
virus in fresh tissue. They interpreted this finding by concluding that the 
membrane exposed to inactivated virus had released a factor (IFN) which 
conferred resistance to virus.
Subsequent work demonstrated that IFN was a proteinaceous factor 
produced transiently by virus infected cells, that does not directly inactivate 
virus or interfere with viral adsorption at the cell surface but induces a virus- 
resistant state in the surrounding cells (Isaacs et al., 1957; Lindenmann et 
al., 1959; Rubin, 1961; Taylor, 1964). Interferon-like molecules were soon 
found to be produced by a variety of cell types from different species (Henle 
et al., 1959; Ho and Enders, 1959a, 1959b; Tyrell, 1959), and it is now 
known that most viruses stimulate the production of IFN in virtually all 
vertebrate cells both in vivo and in tissue culture (Stewart, 1979).
1.3 Non-viral inducers of IFN.
The first report of a non-viral inducer of interferon showed that 'foreign* 
non-viral nucleic acids were capable of activating the synthesis of type I
1
IFN (Isaacs et al., 1963; Rotem et al., 1963). Subsequently, numerous type I 
IFN-inducing substances were identified, including mycoplasma (Rytel and 
Jones, 1966), bacteria (Younger and Stinebring, 1964), fungal extracts 
(Kleinschmidt et al., 1964), natural and synthetic double-stranded RNA 
(dsRNA)(Rotem et al., 1963; Field et al., 1967), endotoxins (Ho, 1964), 
polysaccharides (Claes et al., 1970), various low molecular weight 
compounds (Diederich et al., 1973; Meindl et al., 1976) and cytokines such 
as colony stimulating factor (CSF-1; Moore et al., 1984; Warren and Ralph, 
1986) and interleukin-1 (IL-1; Van Damme et al., 1985). Type II IFN is 
induced by either antigens (Green et al., 1969) or mitogens (Wheelock, 
1965).
1.4 Classification of IFNs.
IFNs were originally categorized into three distinct groups by virtue of 
their cellular origin; leukocyte IFN (mainly consisting of IFN-a), fibroblast 
IFN (mainly consisting of IFN-p) and immune IFN (the mitogen- or antigen- 
induced species of lymphocytes) (Gresser, 1961; Wheelock, 1965; Falcoff 
et al., 1972; Havell et al., 1975). Because of their similar physical and 
chemical properties, in particular their resistance to acid (pH 2) and heat 
(65 °C), leukocyte and fibroblast IFNs were grouped together as type I IFN, 
while immune IFN, which is sensitive to acid and to heat was designated as 
type II IFN.
The original IFN nomenclature based on the cellular origins of the IFN 
proved to be unsuitable, since many cell types produce a heterogeneous 
mix of IFNs. Leukocytes, for instance, secrete IFN-p as well as several 
related forms of IFN-a (Havell et al., 1975; Cavalieri et al., 1977; Allen and 
Fantes, 1980). IFN-a, -p and -y were distinguished immunologically and 
were subsequently reclassified strictly on the basis of antigenic specificity, 
as IFN-a (leukocyte IFN), IFN-p (fibroblast IFN) and IFN-y (immune IFN; 
Stewart et al., 1980). Upon cloning the individual IFN-a subtypes were 
recognized and designated IFN-a1, IFN-a2 etc.
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1.5 Mechanisms of IFN induction of the antiviral state of 
the ceil.
The action of IFNs are mediated through interactions with high affinity 
receptors in the cell membrane. Upon the binding of IFN, the IFN receptors 
are internalized and degraded (Aguet and Morgensen, 1984). IFN-a and -p 
appear to utilize a common receptor (Aguet and Morgensen, 1984; Zoon 
and Arnheiter, 1984) while IFN-y utilizes a separate receptor (Branca and 
Baglioni, 1981; Orchanski et al., 1984; Merlin et al., 1985), for which the 
cDNA has recently been isolated (Aguet et al., 1988). It is unknown how the 
receptor/IFN complex mediates its effect to the nucleus, though evidence 
suggests internalization of type I IFN is not sufficient (Higashi and Sokawa, 
1982; Huez et al., 1983; Arnheiter and Zoon, 1984) nor necessary (Ankel et 
al., 1973) to induce the antiviral state and that IFN may act before being 
internalized.
Establishment of the antiviral state by interferons requires RNA and 
protein synthesis (Lockhart, 1964; Taylor, 1964) and is accompanied by the 
synthesis of many new proteins (Weil et al., 1983). In most cells, IFN 
induces 15 to 20 different genes (Revel and Chebath, 1986), of which the 
majority are poorly characterized, as either encoding IFN-inducible 
proteins detected by two dimensional electrophoresis (Weil et al., 1983) or 
IFN-inducible cDNAs, coding proteins with no homology to any known 
protein (Friedman et al., 1984).
Some IFN-inducible proteins have been identified, such as class I and II 
histocompatibility antigens (Gresser, 1984; Rosa and Fellous, 1984), p-2 
microglobulin (Wallach et al., 1982), guanylate binding proteins (Cheng et 
al., 1983), methallothionein II (Friedman et al., 1984) and thymosin p4 
(Revel and Chebath, 1986; (derived from the 6-26 gene (Friedman et al.,
1984)), though the role they play, if any in the establishment of the antiviral 
state is still unclear (Revel and Chebath, 1986). The function of three 
IFN-inducible proteins, 2,-5'-oligoadenylate synthetase, a dsRNA- 
dependent protein kinase and the Mx gene product have been described.
Protein synthesis in cell free extracts prepared from IFN-treated cells 
was found to be extremely sensitive to inhibition by dsRNA (Kerr et al.,
1974). This phenomenon has been shown to be due to the activation of two 
interferon-induced, dsRNA-activated enzymes, 2'-5'-oligoadenylate
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synthetase and a dsRNA dependent protein kinase, which ultimately 
results in the inhibition of protein synthesis and consequently inhibition of 
viral growth (Baglioni, 1979).
Expression of 2'-5'-oligoadenylate (2-5A) synthetase is strongly induced 
by IFN, and requires the presence of dsRNA for activation. 2-5A synthetase 
converts ATP to oligonucleotides with the general structure ppp5'(2'p5'A)n 
(where n>2), commonly referred to as 2-5A (Kerr and Brown, 1978; 
Zilberstein et al., 1978). These oligonucleotides activate RNase L, an 
endogenous endonuclease which degrades both rRNA and mRNA, 
thereby inhibiting protein synthesis (Baglioni et al., 1979). After activation, 
RNase L, which is not induced directly by IFN (Silverman et al., 1982), 
cleaves RNA on the 3' side of UN sequences with a preference for UU and 
UA (Floyd-Smith et al., 1981; Wreschner et al., 1981).
2-5A is degraded to AMP and ATP by a second IFN-induced enzyme, 
2,-5f phosphodiesterase. This enzyme may play a role in regulating the 
transient effect of 2-5A synthetase (Schmidt et al., 1979). In addition to its 
phosphodiesterase activity, it has been shown to remove the CCA terminus 
from tRNA and this may also result in inhibition of protein synthesis 
(Schmidt et al., 1979).
Although it is clear that the 2-5A synthetase system does not inhibit the 
replication of all viruses (Masters and Samuel, 1983; Munoz and Carrasco, 
1983; Hersch et al., 1984), evidence for its contribution to the establishment 
of the antiviral state was obtained by demonstrating that in cells 
microinjected with 2-5A synthetase, growth of vesicular stomatitis virus 
(VSV) was effectively inhibited (Higashi and Sokawa, 1982). Furthermore, 
the extent of constitutive expression of 2-5A synthetase cDNA in Chinese 
hamster ovary cells directly correlates with resistance against Mengo virus 
(Chebath et al., 1982). Surprisingly though, in the light of the results of 
Higashi and Sokawa (1982), constitutive expression of 2-5A synthetase 
was found to be insufficient to confer resistance against VSV to CHO cells 
(Chebath et al., 1982).
Treatment of cells with IFN results in the induction of the 48 and 68 kDa 
subunits of a 110 kDa protein kinase. In the presence of dsRNA, the 48 kDa 
subunit phosphorylates the 68 kDa component, activating an intrinsic 
protein kinase activity. This interferon-induced dsRNA-activated protein 
kinase phosphorylates other substrates including the a-subunit of the
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eukaryotic protein synthesis initiation factor 2 (elF2a (Farrell et al., 1977)) 
and some histones (Roberts et al., 1976; Sen et al., 1978; Zilberstein et al., 
1978).
Phosphorylation of the a-subunit of elF2 results indirectly in the 
inhibition of protein synthesis by preventing the regeneration of elF2-GTP 
elF2 is needed for the formation of the methionyl-tRNA-40S ribosomal 
subunit complex required for the initiation of translation (Cooper and Forell, 
1977; Lewis et al., 1978; De Benedetti et al., 1983). Following the formation 
of the methionyl-tRNA-40S complex the elF2 is released in an inactive form 
bound to GDP. Normally the elF2-associated GDP is exchanged with GTP 
to generate active elF2-GTP. When phosphorylated the elF2 becomes 
irreversibly bound to the GDP and thus cannot be recycled resulting in an 
inhibition of protein synthesis.
The role that the phosphorylation of histones by dsRNA-dependent 
protein kinase plays in the effects induced by IFN is not known (Baglioni et 
al., 1979); it has been postulated that it may effect transcription by altering 
the chromatin structure, however, evidence for such an effect is not 
available.
Both 2-5A synthetase and dsRNA-dependent protein kinase pathways 
are believed to be directed against viruses which produce dsRNA as part of 
their normal life cycle, which then activates the latent activity of these 
IFN-induced enzymes (Baglioni et al., 1979).
Currently, the murine Mx gene is one of the best studied of the 
IFN-inducible genes shown to play a role in the protection of cells against 
viral infection. Unlike the non-specific actions of the dsRNA-activated 
enzymes, the Mx gene product, a 72 kDa karyophilic protein induced by 
type I IFNs (Horisberger et al., 1983; Dreiding et al., 1985), specifically 
confers resistance against orthomyxoviruses (Lindenmann, 1964; Haller et 
al., 1979; Arnheiter et al., 1980; Arnheiter and Staeheli, 1983; Staeheli et 
al., 1984). It has been proposed that Mx acts by preventing transcription 
(Krug et al., 1985; Ransohoff et al., 1985) and/or translation (Meyer and 
Horisberger, 1984) of the viral mRNA. Evidence that the Mx gene product, 
in the absence of other IFN-mediated effects is directly responsible for viral 
resistance was obtained by constitutively expressing Mx cDNA in Mx“ cells 
and demonstrating that this conferred resistance against influenza virus, 
but not vesicular stomatitis virus (a rhabdovirus; Staeheli et al., 1986).
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Constitutive expression of Mx cDNA was also shown to confer resistance 
against influenza virus to non-murine cells (Noteborn et al., 1987).
Homologues of the murine Mx protein exist in humans (Horisberger and 
Hochkeppel, 1987), cattle (Horisberger, 1988), rats (Meier et al., 1988) and 
fish (Staeheli et al., 1989) and seem likely to confer resistance to 
orthomyxo or orthomyxo-like viruses. A second murine Mx gene (Mx2) has 
been identified whose hypothetical protein when aligned for the best fit with 
the murine Mx protein (Mx1) displays a 73% homology (higher in exons 3 
to 8 (Staeheli and Sutcliffe, 1988; Aebi et al., 1989)). However, due to a 
frame shift mutation, it seems unlikely that this gene encodes a functional 
protein (Staeheli and Sutcliffe, 1988). Similar families of Mx-related 
proteins and mRNA, which probably arose from a common ancestral gene 
by duplication (Staeheli and Sutcliffe, 1988), exist in other species 
including humans (Aebi et al., 1989), cattle (Horisberger, 1988) and rats 
(Meier et al., 1988). A comparison of human and mouse Mx proteins show 
that the human MxA and murine Mx2 proteins are the most closely related, 
displaying 77% homology (Aebi et al., 1989). Surprisingly, the MxA gene 
product which is cytoplasmic not only confers resistance to influenza virus 
but also to vesicular stomatitis virus (Aebi et al., 1989; J. Pavlovic, 
unpublished results) suggesting that Mx-related genes may confer 
resistance against a wider variety of viruses than was at first thought.
1.6 Non-antiviral effects of IFN on the cell.
Beside their antiviral effects, both type I and II IFNs are now recognized 
as regulators of a variety of cellular functions, including proliferation, 
differentiation and various immunological reactions (De Maeyer and De 
Maeyer-Guignard, 1988). Since the first report of the antiproliferative effect 
of IFNs on mouse fibroblasts (Pauker et al., 1962), IFNs have been shown 
to inhibit the division of normal and transformed cells (Lindahl-Magnusson 
et al., 1972; Balkwill and Oliver, 1977; Balkwill et al., 1978; Gresser and 
Tovey, 1978; Van’t Hull et al., 1978; Pfeffer et al., 1979).
Although the molecular mechanism of the antiproliferative effects of type 
I IFN is as yet unknown, the fact that IFN inhibits the expression of several 
proto-oncogene products implicated in cellular proliferation (including 
c-myc and c-fos; Giovanna et al., 1989) and that IFN is itself induced by
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some of the same proteins (Giovanna et al., 1989) or other factors which 
stimulate them (Kelly et al., 1983; Greenberg and Ziff, 1984; Kruijer et al., 
1984; Muller et al., 1984) suggests that IFN may be involved in the negative 
feed-back control of these proto-oncogenes. By negatively regulating the 
expression of factors required for cellular proliferation, IFN may induce an 
inhibitory effect on cell growth.
Type I IFN treatment of Daudi cells induces a cell surface protein, the 
expression of which correlates with the suppression of cell proliferation 
(Hillmann et al., 1987). This 17 kDa protein has been partially purified from 
membranes of induced Daudi cells and can inhibit the growth of Daudi, 
Namalwa and Hela cells. Although the function of this protein is unknown, it 
could potentially play a central role in the IFN induced inhibition of cell 
division.
Several immunological processes are influenced by IFN in both an 
inhibitory and stimulatory manner. For example, type I IFN severely inhibits 
the formation of antibody-producing cells (Braun and Levy, 1972) in 
contrast to IFN-y which stimulates the generation of these cells (Nakamura 
et al., 1984). IFN-y and to a lesser extent IFN-a suppresses monocyte 
migration (Thurnan et al., 1984), while type I IFN inhibits the maturation of 
monocytes to macrophages (Lee and Epstein, 1980) and suppresses 
delayed hypersensitivity reactions (DeMaeyer et al., 1975). In the presence 
of type I IFN there is a stimulation of several functions including 
phagocytosis by macrophages (Donahoe and Huang, 1976) cytotoxicity of 
sensitized lymphocytes (Einhorn et al., 1978) and expression of 
immunoglobulin receptors (Friedman et al., 1980). Both type I and type II 
IFNs stimulate the expression of histocompatability antigens (class I and 
class II (Gresser, 1984; Rosa and Fellous, 1984)) and natural killer cell 
activity (Gidlund et al., 1978; Djeu et al., 1978; Weigent et al., 1983).
Very low levels of constitutively expressed IFN-a transcripts are 
produced in the spleen, kidney, liver and peripheral blood leukocytes of 
healthy individuals (Tovey et al., 1987). This finding raises the possibility 
that the constitutive expression of IFN in vivo may play a role in the 
regulation of physiological processes such as immune recognition, 
differentiation, hematopoiesis and cell proliferation. Furthermore, human 
IFN has been detected in placental blood (Duc-Goiran et al., 1985) and 
amniotic fluid (Lebon et al., 1982), and it has been postulated that it may
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play a role in fetal development or alternatively, help to maintain maternal 
tolerance.
Maternal recognition of pregnancy in sheep is dependent upon 
secretion of ovine trophoblast protein-1 (oTP-1) by the conceptus. The 
cDNA for this protein was cloned and the primary amino-acid sequence 
deduced from the nucleotide sequence (Imakawa et al., 1987). oTP-1 was 
found to display, throughout its length, striking amino-acid sequence 
homology with IFN-as from a variety of species; the most extensive 
homology, 70.3%, is with bovine IFN-an (Imakawa et al., 1987). Purified 
oTP-1 has potent antiviral activity (107-108 units /mg) and is thus about as 
active as any known IFN (Pontzer et al., 1988; Roberts et al., 1989). Thus it 
appears that oTP-1 belongs to a subfamily of IFNs with a highly specialized 
function. cDNA clones corresponding to bovine trophoblast protein-1 
(bTP-1) have been isolated and the inferred primary structure also 
indicates that it could be an IFN (Imakawa et al., 1989).
1.7 Cloning of the IFN cDNAs.
The development of recombinant DNA technology heralded a major 
breakthrough in the understanding of the IFN system, allowing the cloning 
of several distinct species of IFN cDNAs. Synthesis of IFN in E. coli and 
yeast enabled for the first time the isolation of substantial amounts of pure 
single IFN species, allowing their properties to be investigated 
unambiguously, in the absence of contaminating proteins. In addition, 
recombinant DNA technology allowed the chromosomal sequences of the 
IFN genes to be identified and the control of expression of these genes to 
be studied.
1.7.1 IFN-a cDNAs.
The first IFN cDNA clone to be isolated was that of IFN-a1 (Nagata et al., 
1980a), by a process that relied on the ability of Xenopus oocytes to 
synthesize detectable amounts of IFN when microinjected with as little as 
50ng of poly (A) RNA isolated from IFN producing cells (Reynolds et al.,
1975). Poly(A) RNA was isolated from human leukocytes infected with 
Sendai virus and fractionated by sucrose gradient centrifugation. Fractions
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containing IFN mRNA, as detected by the oocyte assay were pooled. The 
approximately 10 fold enriched mRNA was then used as a template for the 
synthesis of double-stranded cDNA which was subsequently inserted into 
pBR322 and used to transform E. coli. The resulting transformants (-5000) 
were divided into pools of around 500 and rescreened in a hybridisation- 
translation assay (Harpold et al., 1978). The hybrid plasmids from each 
pool were denatured and irreversibly bound to filters which were then 
hybridized with virus-induced leukocyte mRNA. Hybridizing mRNA was 
recovered, injected into oocytes and homogenates were assayed for IFN 
activity. Positive pools were subdivided and reassayed until a single clone 
was identified. The cDNA insert of the isolated clone was shorter than 
expected (320 bp) and was thus used as a hybridization probe to search 
for additional clones with longer inserts. A plasmid was identified (Hif-2h) 
with a cDNA insert of 910 bp, corresponding to the expected length of a 
complete IFN cDNA. Confirmation that this clone did in fact encode for IFN 
was obtained by showing that it hybridized to IFN mRNA and that after 
expression in E. coli IFN activity was produced which could be neutralized 
by anti-IFN-a antibodies.
Nucleotide sequence analysis of the cDNA insert of Hif-2h (IFN-a1) 
enabled the prediction of the amino acid sequence of its open reading 
frame (Mantei et al., 1980) and comparison with the amino terminal 
sequence of lymphoblastoid IFN, which had recently been determined by 
Zoon et al. (1980). Surprisingly, the two IFNs sequences differed in 5 out of 
20 positions, arousing the suspicion that more than one type of IFN-a might 
exist.
Using the IFN-a1 cDNA as a probe, a second IFN producing clone was 
identified (IFN-a2) which in addition to displaying a different target 
specificity to IFN-a1, differed in 17% of its amino acids and in 5 out of 33 of 
the amino terminal residues of lymphoblastoid IFN (Streuli et al., 1980). It 
therefore became clear that at least 3 different forms of IFN-a existed and 
that the multiple peaks of IFN-a activity separated by HPLC (Rubinstein et 
al., 1979) were potentially the products of multiple genes and not one form 
of IFN-a differing in its degree of glycosylation. Goeddel et al. (1981) 
estimated from Southern analysis that at least 10 IFN-a genes existed and 
using an IFN-a cDNA as a probe identified 8 distinct IFN cDNAs. Isolation 
of chromosomal clones revealed that at least 24 IFN-a genes existed of 
which 15 are potentially active and 9 encode pseudogenes (Nagata et al.,
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1980b; Brack et al., 1981; Henco et al., 1985; Weissmann and Weber, 
1986). Multiple forms of IFN-a were also detected in many vertebrates 
including mouse (Shaw et al., 1983; Kelly and Pitha, 1985; Zwarthoff et al.,
1985), cattle (Capon et al., 1985), rat (Dijkema et al., 1984), and monkey 
(Pestka, 1986).
1.7.2 IFN-p cDNA.
The first successful cloning of an IFN-p cDNA was reported by Taniguchi 
et al. (1979) who used a two step approach of differential hybridization (St. 
John and Davis, 1979; Hoeijmakers et al., 1980) followed by hybridization- 
translation (Harpold et al., 1978) to identify single IFN-p clones. Double­
stranded cDNA was prepared from 12S poly(A) RNA isolated from poly 
rl-rC-induced fibroblasts enriched for IFN mRNA and clones were screened 
with radioactive cDNA prepared from induced and uninduced libraries 
respectively. Colonies hybridizing with the induced but not the uninduced 
cDNA were selected for further analysis. A hybridization-translation assay, 
similar to that employed in the cloning of the IFN-a1 cDNA (see above) was 
then used to identify the IFN-p clones amongst those selected by 
differential hybridization, enabling individual IFN-p clones to be identified. 
Confirmation that the isolated cDNA was in fact that of IFN-p was obtained 
(Taniguchi et al., 1980a) when the predicted amino acid sequence was 
found to agree with the amino terminal sequence of IFN-p obtained by 
Knight et al. (1980). Additional evidence that this clone was an IFN-p cDNA 
was presented when it was demonstrated that the cDNA when expressed 
in E. coli produced a polypeptide with IFN activity (Taniguchi et al., 1980b). 
Two independent isolations of IFN-p cDNAs were subsequently made 
which in addition to possessing an identical nucleotide sequences to the 
clone of Taniguchi, produced biologically active IFN when expressed in E. 
coli (Derynck et al., 1980a, 1980b; Goeddel et al., 1980; Taniguchi et al., 
1980c). Evidence obtained from Southern analysis indicated indicated that 
unlike IFN-a, IFN-p was not a member of a multi-gene family (Goeddel et 
al., 1981; Wilson et al.,1981).
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1.7.3 IFN-y cDNA.
Two IFN-y cDNA clones were independently isolated at about the same 
time utilizing a differential hybridization assay (Gray et al., 1982) or the 
hybridization-translation approach (Devos et al., 1982). Nucleotide 
sequence analysis showed that the two cDNAs were almost identical and 
that when expressed in E. coli or monkey cells produced IFN activity that 
was acid labile and neutralized by anti-lFN-y antibodies but not those 
against IFN-a or -p. The identification and cloning of a single IFN-y 
chromosomal gene, Southern analysis (Gray et al., 1982; Gray and 
Goeddel, 1983; Taya et al., 1982) and the existence of a single 
homologous IFN-y mRNA in lymphocyte and spleen cells (Derynck et al.,
1982) all indicate that a single IFN-y gene exists in man.
1.8 Structure of the IFN genes.
1.8.1 IFN-a genes.
The large number of IFN-a genes isolated to date can be divided into 
two subfamilies; subfamily IFN-a| which consists of at least 15 genes of 
which 14 are thought to be functional and subfamily IFN-a|| w‘^  6 genes of
which one is functional (reviewed in Weissmann and Weber, 1986). The 
genes of IFN-a| subfamily diverge from each other by less than 13% in 
replacement sites and 35% in silent sites, whereas the IFN-a||1 gene
diverges by at least 28% and 62% in replacement and silent sites, from all 
members of the IFN-a| family (Henco et al., 1985). All the IFN-a genes lack
introns, encode leader sequences of 23 amino acids (with one exception 
which may have a leader of 16 amino acids) which are cleaved off during 
maturation to produce active IFN molecules of usually 166 amino acids 
(human IFN-a2 is 165 and human IFN-aj|1 172 residues long), and have
5'-non-translated regions of 67 to 69 nucleotides (nt) and 3'-non-translated 
regions of between 240 and 440 nt (reviewed in Weissmann and Weber,
1986). A comparison of the amino acid sequence of all known IFN-a loci 
reveals regions of strong conservation, particularly amino acids 135 to 151, 
which in addition to being conserved between all human IFN-a proteins 
are conserved in other species, as well as in IFN-p (see Figure 1 in 
Weissmann and Weber, 1986). All known human IFN-a genes lie on
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chromosome 9 (Owerbach et al., 1981; Shows et al., 1982) and several are 
within a few kilobases of each other (Brack et al., 1981), while others are 
less closely linked.
1.8.2 IFN-p gene.
The human IFN-p is a single copy gene (Goeddel et al., 1981; Wilson et 
al., 1983) which encodes a preprotein of 187 amino acids from which a 
signal peptide of 21 amino acids is cleaved off upon maturation (Derynck et 
al., 1980a; Goeddel et al., 1980). Its 5'-non-translated sequence is between 
73 and 76 nt in length and the 3'-non-translated region comprises of 
approximately 200 nt. As the IFN-a genes, the IFN-p gene contains no 
introns (Lawn et al., 1981; Ohno and Taniguchi, 1981) lies on chromosome 
9 (Meager et al., 1979; Owerbach et al., 1981; Shows et al., 1982) and is 
closely linked to the IFN-a genes (Ohlsson et al., 1985). A single IFN-p 
gene has been shown to exist in all vertebrates tested, except for 
ungulates, which possess several IFN-p genes (Wilson et al., 1983; Leung 
etal., 1984).
1.8.3 IFN-y gene.
A single IFN-y gene exists in man, which in contrast to the type I IFN 
genes contains 3 introns (Gray and Goeddel, 1983; Taya et al., 1982) and 
is located on chromosome 12 (Nayor et al., 1983). The gene encodes a 
product of 166 amino acids from which a 20 amino acid signal peptide is 
cleaved to form the mature product of 146 amino acids (Gray et al., 1982; 
Devos et al., 1982). It has 127 and 584 nucleotide 5'- and 3'-non-translated 
sequences, respectively. Two species of IFN-y exist, of 20 and 25 kDa (Yip 
et al., 1982), this heterogeneity is ascribed to varying degrees of 
glycosylation (Kelker et al., 1984). The IFN-y genes of mouse (Gray and 
Goeddel, 1983), rat (Dijkema et al., 1985) and cattle (Derynck, 1983) have 
been cloned and all species examined contain a single IFN-y gene with 
introns in positions corresponding to those of the human gene.
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1-9 Evolution of the IFN genes.
The similarity between the IFN-a and -p genes (45% at the nucleotide 
and 29% at the amino acid level (Taniguchi et al., 1980d)) indicates that in 
all probability they diverged from a common ancestor. It is assumed that 
sequence divergence between two homologous genes in different species 
is proportional to the time elapsed since the separation of the species. 
Based on this assumption it should be possible to estimate the divergence 
of the IFN-a and -(3 genes within a species, although the calculation is 
complicated by the unknown frequency of gene rectification (as a result of 
gene conversion and recombination), allowing only the minimum time 
since the gene duplication occurred to be estimated. Weissmann and 
Weber (1986) calculated that the IFN-a and -p genes probably diverged 
some 200-300 million or more years ago.
The relationship of the IFN-y gene to the IFN-a and -p genes is not easy 
to gauge. Although no significant homologies are apparent at the 
nucleotide level, appropriate alignment suggests there may be 
conservation of several amino acid clusters and single residues between 
the various IFN species (DeGrando et al., 1982; Epstein, 1982; Gray and 
Goeddel, 1983). Whether these blocks of homology are significant (ie. 
evidence for a common ancestor) or the result of sequence constraint 
dictated by the convergent evolution of the IFN proteins has not been 
determined. If the IFN-y gene is derived from the same ancestor as IFNs -a 
and -p then it must have branched off much earlier than the -a and -p 
genes.
All mammalian species examined possess a large IFN-a gene family, 
hence it was probably established some time prior to the divergence of 
mammals, 85 million years ago (Weissmann et al., 1982). The divergence 
of the individual IFN-a genes indicates that their origin is far more recent 
(23 million years ago (Miyata and Hayashida, 1982)) but as discussed 
above this should be taken only as a minimum indication of the divergence 
of these genes. Two possible explanations have been proposed to explain 
the origins of multiple gene families, either sequential duplication of the 
genes, spread over a long evolutionary period (Ohno, 1970) or a 'big bang’ 
event resulting in the duplication of multiple copies of the same gene in 
germ cells during a single generation, such events have been shown to 
occur in somatic cells (Edlund and Normack, 1981). Either of these events
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could explain the origin of the IFN-a gene family. Once duplicated, the 
individual members would begin to diverge by acquiring deletions, 
insertions and substitutions resulting in the heterogeneity now seen in the 
IFN-a gene products.
Presumably the IFN-p gene family of ungulates arose by similar events. 
As the pig, horse and cow all possess multi-member IFN-p gene families 
and other mammals do not, the amplification of the -p gene probably 
occurred some time between the radiation of mammals and the divergence 
of the ungulates ie. between 55 and 85 million years ago.
1.10 IFN gene expression is under differential control.
Hiscott et al. (1984a) studied the expression of several IFN genes using 
the S1 assay, under conditions that allowed for the specific and 
quantitative detection of the individual IFN gene transcripts. They showed 
that the IFN-a genes and the IFN-p gene are transcribed in a differential, 
cell specific manner. In different cell lines the ratio of different IFN 
transcripts are not uniform, for example leukocytes express twice as much 
IFN-a1 as IFN-a2 or -p whereas in Namalwa cells IFN-p was expressed at 
levels 3 and 5 times higher than that of IFN-a1 and -a2 respectively. Some 
of the other IFN-a subtypes are also subject to differential expression, but 
generally the differences in expression are less pronounced. The ratios of 
the the individual IFN-a mRNAs were shown to vary considerably within a 
particular cell type, in general, IFN-a1, -a2 and -a4 represented the major 
species, while IFN-a5, -a7, -a8 and -a14 transcripts were present at 5 to 20 
fold lower levels (Hiscott et al., 1984a, 1984b). The use of various induction 
protocols did not significantly affect the proportion of IFN transcripts and 
surprisingly the number of IFN transcripts did not always correlate with IFN 
activity.
In order to investigate the potential role the various a-IFNs play during 
differentiation, the transcript levels of several species of IFN in peripheral 
blood leukocytes of heathy and leukemic individuals after induction by 
Sendai virus was measured (Hiscott et al., 1984b; Streuli, 1986). Leukemic 
leukocytes are arrested at different stages of hematopoietic differentiation 
(Klein, 1984) and thereby offer a system in which the expression of the IFN 
genes can be studied at various stages of differentiation. Certain leukemic
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leukocytes not belonging to the monocyte/macrophage lineage, showed 
striking differences in the proportion of the individual IFN-oc mRNA species 
they produced when compared to each other and to normal lymphocytes 
(Streuli, 1986). This observation lends weight to the idea that the individual 
IFN subtypes may play distinct roles in the regulation of hematopoietic 
differentiation and/or cell growth.
1.11 The individual IFN-a subtypes may have different 
functions.
The multiplicity of IFN-a genes and the fact that certain of the IFN-a sub- 
types are differentially rather than coordinately controlled raises the 
question of whether the individual IFN-a species preferentially carry out 
different functions. It has been well established that the individual IFN 
subtypes display distinct differences in their target specificity when tested 
on cell lines from different species (Desmyter and Stewart, 1976; Lin et al., 
1978; Streuli et al., 1980; Streuli et al., 1981; Week et al., 1981a, 1981b; 
Yelverton et al., 1981) and even on cell lines from the same species (Week 
et al., 1981a; Goren et al., 1983). Furthermore, the degree of stimulation by 
different IFN-a species of the various activities such as antiviral activity, 
natural killer cell activation, antiproliferative activity and 2-5A synthetase 
induction etc., differs between cell lines (Rehberg et al., 1982; Goren et al.,
1983) and even within the same cell type (Week et al., 1981a). These 
findings imply that the different forms of IFN-a may have different functions. 
It has been suggested that this may come about if cells have more than one 
type of IFN-a receptor to which the the IFN-a species have varying affinities 
and if different cells lines have different proportions of these receptors 
(Weissmann and Weber, 1986).
1.12 Control of IFN gene expression.
By stably transfecting mouse L929 cells with the human IFN-a1 gene, 
Mantei and Weissmann (1982) demonstrated that it was possible to obtain 
correctly initiated human IFN-a1 mRNA, upon induction with Newcastle 
disease virus (NDV). The kinetics were similar to those seen for the 
endogenous IFN genes. Similar work by a number of other labs using a
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variety of vector systems and cell lines gave similar results with the human 
IFN-p gene (Canaani and Berg, 1982; Hauser et al., 1982; Ohno and 
Taniguchi, 1982; Zinn et al., 1982; Mitrani-Rosenbaum et al., 1983). 
Transfer of the IFN genes into foreign cells provided a system in which 
genes modified by DNA reconstruction or site-directed mutagenesis could 
be tested in vivo, in the quest to identify the cis-acting sequences required 
for IFN gene regulation. Furthermore, the observation that relatively short 
chromosomal fragments encoding the IFN genes contained sufficient 
information for the accurate regulation of these genes in foreign cells gave 
the first indication of the location of these cis-acting DNA sequences.
1.13 The S'-flanking sequences of the IFN genes mediate 
viral induction of transcription.
The steady state level of an mRNA in the cell is determined by the rate of 
synthesis and degradation of the transcript. Thus, accumulation of IFN 
mRNA following induction could arise by either the stabilization of rapidly 
turning over mRNA or the activation of transcription from previously silent 
genes or a combination of both. To clarify this issue, Weidle and 
Weissmann (1983) introduced into L929 cells a hybrid gene in which the 
5'-flanking sequence derived from the IFN-a1 gene was fused to the rabbit 
p-globin transcription unit. Correctly initiated and spliced p-globin 
transcripts were detected only after infection with NDV, with kinetics similar 
to those described for the endogenous IFN mRNAs. Transcription from a 
construct with the p-globin promoter linked to the IFN-a1 transcription unit, 
or from the complete p-globin gene was constitutive and upon NDV 
induction a decrease in the transcript levels was observed (Weidle and 
Weissmann, 1983). A similar approach with the human IFN-p gene 
illustrating that a hybrid gene consisting of the 5'-flanking region of IFN-p 
gene linked to a thymidine kinase transcriptional unit was also virus 
inducible (Ohno and Taniguchi, 1983), demonstrating that activation of 
transcription of the IFN-p as well as the IFN-a gene is mediated by 
elements located in the 5' regions of these genes.
Raj and Pitha (1983) studied the induction of the endogenous IFN-p 
gene using nuclear run-on experiments and concluded that the 
accumulation of IFN-p transcripts following induction is the result of both 
activation of transcription as well as stabilization of the transcripts. The role
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of transcript stabilization was confirmed by Nir et al. (1984) who used a 
truncated IFN-p gene (retaining 5' sequences to position -40) which 
synthesized IFN-p RNA at a constant rate whether the cell was induced or 
not, and showed that upon induction, stabilization of IFN-p mRNA resulted 
in an accumulation of IFN-p transcripts in the cell. In contrast, Whittemore 
and Maniatis (1990) found no evidence that mRNA stability was regulated 
during viral induction of the IFN-p gene. Instead they showed that IFN-p 
mRNA decayed at a constant rate throughout induction and that the post­
induction decrease in transcript levels is due mainly to a decrease in the 
rate of transcription.
Shaw and Kamen (1986) noticed that many transiently expressed genes 
(including both type I and II IFNs) contain AU-rich sequences in their 3' 
untranslated regions. These authors showed that the 3' non-coding regions 
of the GM-CSF when joined to the p-globin mRNA mediated a rapid and 
selective degradation of this RNA and postulated that the function of this 
AU-rich sequence may be to direct mRNA degradation. The IFN-p 
transcripts were found to contain such 3' AU-rich destablizing sequences, 
in addition to 5’ destablizing sequences. Both of these destablizing 
sequences were shown to be associated with small increases in the rate of 
deadenylation of IFN-p mRNA (Whittemore and Maniatis, 1990). Deletion of 
the AU-rich region of the IFN-p gene did not lead to an increase in mRNA 
stability indicating that these sequences do not function in induction but 
rather to decrease the transcript level post-induction.
1.14 Localization of the DNA sequences required for the 
regulation of induced expression of the IFN-a and -p 
genes.
1.14.1 The IFN-a1 gene.
Several groups have identified DNA sequences responsible for induced 
transcription of the IFN genes by generating various deletions in the 
5'-flanking regions of the IFN-a1 and -p genes and expressing the resulting 
hybrids in various host cell lines. Ragg and Weissmann (1983) located the 
5' boundary of the region required for inducible transcription of the human 
IFN-a1 gene in L929 cells between positions -117 and -74 with respect to 
the cap site. The 3' boundary of this region was subsequently localized by
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joining segments of the IFN-a promoter extending from position -675 to 
several points between -22 and -117 to a truncated p-globin gene and 
testing for virus induced activation of transcription (Ryals et al., 1985). 
Induction was found to be maximal when the 3' end point was -64, and 
there was a stepwise loss of activity as the truncations extended further 
upstream until at position -86 inducibility was completely lost. The 5' 
boundary was further mapped by constructing 5' deletions of a hybrid 
IFN-a promoter which extended to position -64 on the 3’ side. Deletions 
extending to position -109 left the promoter fully inducible while further 
truncations reduced the inducibility stepwise until at position -79 it was 
completely abolished (Ryals et al., 1985). Thus, a 46 base pair (bp) 
sequence located between positions -109 and -64 was shown to be 
required for the maximal induction of the IFN-a1 gene while a segment of 
only 22 bp (positions -85 to -64) was shown to retain marginal virus 
inducibility (Figure 1).
Subsequent work by Kuhl et al. (1987) showed that sub-sequences of 
the 46 bp virus-responsive element of the IFN-a1 gene (VREal) were 
themselves virus inducible when multimerized. VREal consists of 
essentially two 19 bp repeats, repA and repB (see Figure 1) and it was 
found that tetramers of repA (tetra-repA) or of the hexanucleotide GAAAGT, 
which is present in repB, were both able to confer virus inducibility on a 
reporter gene. In addition, both tetra-repA and (GAAAGT)4, but surprisingly 
not VREal, when inserted between an enhancer and a TATA box, caused 
suppression of the constitutive activation of transcription elicited by the 
enhancer. This suppression was fully abrogated by virus induction and was 
therefore designated 'reversible silencing' (Kuhl et at., 1987). This result 
and the observations by Ryals et al. (1985), that there was a stepwise drop 
in inducibility as VREal was truncated, implies that multiple sequence 
motifs (which when multimerized are themselves virus inducible) contained 
in VREal may function cooperatively to contribute to induction.
1.14.2 The IFN-p gene.
Several groups identified the DNA sequences required for the induction 
of the human IFN-p gene and while they all essentially agreed on the 3' 
boundary, results for the 5' boundary differed from group to group. Fujita et 
al. (1985) constructed various IFN-p deletions and introduced them into
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Figure 1 Comparison of the IFN-a1 and IFN-p promoter regions 
(adapted from Kuhl et al., 1987).
Numbering is from the cap site of the human IFN-p (Fujita et al., 1985) and the IFN-a1 gene 
(Ryals et al., 1985), respectively. VR Eal (Ryals et al., 1985; Kuhl et al., 1987) and VREp 
(Goodbourn et al., 1985) are indicated by horizontal brackets. Sequences 5' to VREp 
necessary for optimal induction in the experimental system of Fujita et al. (1985) are 
indicated by dotted lines. Boxes above the sequences indicate protected regions in the 
IFN-p promoter (stippled, before induction; vertical stripes, after induction, as identified by 
DNasel genomic footprinting (Zinn and Maniatis, 1986). The two positive regulatory 
domains, PRDI and PRDII, and the negative regulatory domain, NRDI, proposed by 
Goodbourn and Maniatis (1988) are indicated by open boxes. Arrow heads indicate point 
mutations in NRDI that lead to derepression of uninduced transcription (Goodbourn and 
Maniatis, 1988).
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mouse L929 cells. Expression of the mutant genes was measured at both 
the RNA and protein levels, after viral, poly rl-rC or mock induction. In their 
expression system, Fujita et al. (1985) was demonstrated that the upstream 
boundary required to support maximal induction of the IFN-p gene was 
between position -117 and -105 relative to the cap site and that sequences 
downstream of position -40 play no role in viral induction of this gene. The 
sequence requirements for virus and poly rl-rC induction were found to be 
essentially the same. The results were confirmed using a transient 
expression system (Fujita et al., 1987). Similar results were obtained by 
Dinter et al. (1983), who, using permanently transformed murine cells, 
mapped the 5' boundary of the virus responsive element of the IFN-p gene 
to between positions -107 and -68.
Maniatis and coworkers (Zinn et al., 1983; Goodbourn et al., 1985), 
using murine C127 cells transformed by bovine papilloma virus-derived 
vectors carrying various IFN-p deletions, concluded that the 5' boundary for 
induction lies between positions -79 and -75 (numbering according to 
Fujita et al., 1985). By substituting the IFN-p TATA box region (-39 to +74) 
with the corresponding region from the HSV TK gene (-39 to +57), they 
showed that sequences downstream of -40 play no role in the induction of 
the IFN-p gene. Consequently these authors concluded that the virus 
responsive element of the human IFN-p gene (VREp) extends from position 
-39 to -79. Using a different host-vector system these authors obtained 
essentially the same results (cited in Taniguchi, 1988). However, they 
observed that in HeLa cells the sequence requirement for maximal 
induction of the IFN-p gene was similar to that described by Fujita et al. 
(1985). Furthermore, in a transient expression system using C127 cells, 
Goodbourn et al. (1985) found that although a deletion to position -79 did 
not abolish virus inducibility, the presence of additional sequences up to 
position -109 resulted in a 4 fold increase in induced expression.
The different sequence requirements for the maximal induction of the 
human IFN-p gene reported by the various groups could be the result of the 
different assay systems used. Different cell lines may contain varying 
amounts of factor required for the transcriptional control. In a cell line with a 
high factor concentration, the sequence requirement may be less stringent 
than in a cell line that contains lower amounts of the factor. It is also 
conceivable that the expression of the mutant IFN-p genes may be
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influenced by the vector, if for example the vector contains sequences that 
can substitute an activity normally provided by the gene promoter, then 
sequences which are normally essential could become dispensable.
In an attempt to further dissect the region involved in viral activation of 
the IFN-p gene, a series of deletions of the VREp were analyzed 
(Goodbourn et al., 1986). This study indicated that the VREp consists of at 
least two functional elements, a constitutive transcriptional domain (-79 to 
-57) whose activity is controlled by an adjacent negative regulatory 
sequence (-55 to -36).
The active domains of VREp were more accurately located and 
characterized by studying the effect of a large number of single point 
mutations in the VREp had on the relative transcription levels in both 
uninduced and induced cells, in addition to the relative induction ratio 
(Goodbourn and Maniatis, 1988). It was possible to distinguish three 
distinct domains in VREp, two genetically distinct positive regulatory 
domains (PRDI and PRDII) and an overlapping negative regulatory domain 
(NRDI (Figure 1)). Certain point mutations within NRDI resulted in 
increased transcription in uninduced cells, but had little effect in induced 
cells. Such mutations mapped between positions -39 and -55; mutations 
upstream of -55 overlapped with PRDII, so that the 5' boundary of NRDI 
could not be determined, although mutations with a similar phenotype were 
observed at nucleotides -65, -64 and -62, indicating that NRDI may extend 
as far upstream as nucleotide -65.
Mutations in the region -79 to -66 (PRDI) generally resulted in a 
decrease in both induced and uninduced expression and in some cases in 
a lower degree of induction, indicating that PRDI is potentially involved in 
the induction of transcription mediated by VREp. PRDII (-68 to -57) differed 
from PRDI in that mutations in this region resulted in a reduction of 
expression in induced cells only. Presumably in the uninduced state no 
loss of activity was observed as this region is repressed by the adjacent 
NRDI.
Fan and Maniatis (1989) showed that neither PRDI nor PRDII display 
any detectable transcriptional activity as single copies but that any pairwise 
combination of these elements act synergistically as virus-inducible 
sequences. Furthermore PRDI is inducible by both type I and type II IFNs 
and capable of silencing the SV40 enhancer. PRDII however, is not
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inducible by IFN and shows no silencing activity (Fan and Maniatis, 1989). 
Both these elements displayed significant cell type-specific differences 
(Fan and Maniatis, 1989) that may partly explain the different sequence 
requirements identified as being necessary for the maximal induction of the 
p-IFN gene (Dinter et al., 1983; Zinn et al., 1983; Fujita et al., 1985; 
Goodbourn et al., 1985; Fujita et al., 1987).
Within the longer virus responsive element (VREp*; -117 to -39), 
identified by Fujita et al. (1985) are seven copies of a hexamer motif with 
the consensus sequence AAa/gt /g GA (see Figure 1). These authors 
postulated that these hexamers were responsible for the virus induction of 
the IFN-p gene, correlating the loss of one or more of these elements with 
the stepwise reduction in inducibility of the truncated gene (Fujita et al., 
1985; Fujita et al., 1987). Multimers of several of these hexanucleotides 
were shown to mediate virus-induced activation of transcription (Fujita et 
al., 1987). The most active of these hexamers, AAGTGA, when 
multimerized, contributed incrementally to the to the inducibility of a hybrid 
gene in an orientation and distance independent manner, although as a 
single copy it displayed no activity.
1.15 Nuclear factors specifically interact with IFN-p 
promoter elements.
Using gel retardation analysis and DNase I footprinting, Keller and 
Maniatis (1988) identified three distinct VREp binding factors in vitro. Two 
of these were detected in both induced and uninduced nuclear extracts 
(one binding PRDI (PRDI-BFc) the other PRDII (PRDII-BF) while the third, 
binding to PRDI, was detected only in extracts from induced cells 
(PRDI-BFi). The DNA/protein interactions of the two PRDI-binding factors 
were indistinguishable. PRDI-BFi which migrates faster than PRDI-BFc may 
be a proteolytic digestion product of PRDI-BFc or an entirely different 
protein of lower molecular weight. Using the VREp point mutants generated 
by Goodbourn and Maniatis (1988) it was shown that there was a 
correlation between the in vivo activities of these mutants and their ability to 
bind these factors in vitro (Keller and Maniatis, 1988). Furthermore, 
genomic DNase I footprinting of the human IFN-p 5’-flanking region 
indicated that in the uninduced state a factor bound to NRDI which upon
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induction dissociated and is replaced by a second factor binding to PRDI 
(Zinn and Maniatis, 1986).
Fujita et al. (1988) used gel retardation and DNase I footprinting analysis 
to characterize a nuclear factor designated IFN Regulatory Factor-1 (IRF-1) 
that specifically bound to both tetramers of AAGTGA and the VREp’ (this 
activity was later demonstrated to be the result of two distinct factors, IRF-1 
and IRF-2; see below and Harada et al., 1989). Competition experiments 
indicated that IRF-1 had highest affinity for tetrameric AAGTGA (~10 and 80 
fold higher than for VREp' and VREal, respectively) and that the affinity of 
IRF-1 for VREP’ and VREp' mutants correlated with the ability of these 
sequences to mediate virus inducibility in vivo.
1.16 Identification and characterization of VREp binding 
factors.
Miyamoto et al. (1988), using the 'ligand blotting technique' (Singh et al., 
1988), isolated a cDNA encoding a nuclear factor which specifically bound 
to (AAGTGA)4. The DNA binding properties of this factor, expressed in 
E. coli were similar to those of what was first thought to be murine IRF-1 
(but was in fact later recognized to be IRF-2; Fujita et al., 1988; Harada et 
al., 1989). The authors designated this cDNA as IRF-1. It was shown 
subsequently that high level expression of the IRF-1 cDNA in transfected 
COS cells resulted in induction of the endogenous IFN-a and p genes 
(Fujita et al., 1989a). Since IRF-1 is itself virus (and IFN) inducible 
(Miyamoto et al., 1988), it seems likely that IRF-1 is directly involved in virus 
induction of the IFN genes (Harada et al., 1989).
Using IRF-1 cDNA as a probe, a cDNA coding a second factor (IRF-2) 
was identified which displayed 62% homology in its deduced amino acid 
sequence with the N-terminal region of IRF-1. The C-terminal portions of 
these two proteins were only 25% homologous (Harada et al., 1989). The 
DNA binding properties of IRF-2 produced in E.coli when compared to 
IRF-1 were found to be virtually indistinguishable, suggesting that these 
factors bind the same sequences. It was subsequently shown (Harada et 
al., 1989) that IRF-2 was responsible for the 'IRF-1' activity detected in 
uninduced L929 cells by Fujita et al. (1988).
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IRF-2, as IRF-1 is inducible by both virus and IFN, albeit with slightly 
different kinetics (Harada et al., 1989). However only the IRF-1 cDNA was 
able to transactivate the IFN genes upon transfection of COS cells. 
Cotransfection of IRF-2 together with IRF-1 did not significantly affect IFN 
induction; IRF-2 does not seem to function as a repressor in the classical 
sense. The physiological role of IRF-2 is thus unclear and Harada et al. 
(1989) have postulated that it may act as a place holder on the DNA to 
ensure that sequence elements required for activation of the IFN genes by 
IRF-1 are prevented from binding non-specific DNA binding proteins that 
might interfere in transcription, thus keeping the gene in a state readily 
accessible for transcription.
Multimers of AAGTGA contain sequences similar to that of PRDI (see 
below) and therefore it seems likely that PRDI and multimers of AAGTGA 
interact with the same DNA binding factors. Even so, the relationship of 
PRDI-BFc and -BFi with IRF-1 and -2 is not as yet clear. The homology 
shared by PRDI and the consensus sequence of the IFN-responsive 
element (see below) suggests that the pathways of virus and IFN induction 
may overlap, with IRF-1 and -2 playing a role in both. The observation that 
a number of IFN-inducible genes are inducible by virus or dsRNA further 
supports this idea (Tiwari et al., 1987; Wathelet et al., 1987; Hug et al., 
1988).
G AGAAGTGAAAGT G PRDI
AAGt gaAAGTGAAAGTGA (AAGTGA)3
a/Gga AANNGAAAGtTt/c IFN-inducible consensus sequence
(Hug et al., 1988)
Clark and Hay (1989) purified a factor EBP1 which binds a sequence 
present in the SV40 enhancer and noted, as did Hiscott et al. (1989), a 
strong sequence similarity between the PRDII, the EBP1 binding site in the 
SV40 enhancer, the NF-kB binding site in the k light chain enhancer and 
the H2TF1 binding site in the mouse class I histocompatability gene 
enhancer. EBP1 specifically recognized these sequence motifs (Clark and 
Hay, 1989) and it was subsequently shown that upon induction with either 
virus or dsRNA, a factor indistinguishable from NF-kB bound to PRDII, and 
that PRDII and NF-kB binding sites were interchangeable (Fujita et al.,
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1989b; Lenardo et al., 1989; Visvanathan and Goodbourn, 1989). 
Furthermore, point mutations within PRDII that reduce IFN-p induction in 
vivo correlate with a decrease in the affinity that NF-kB has for PRDII in vitro 
(Lenardo et al., 1989; Visvanathan and Goodbourn, 1989).
Mature B cells display significant constitutive NF-kB activity (Sen and 
Baltimore, 1986a; Atchison and Perry, 1987; Lenardo et al., 1987). In other 
cell lines, NF-kB can be activated by lipopolysaccharides (LPS), phorbol 
esters (such as phorbol myristate acetate (PMA)), virus and dsRNA (Sen 
and Baltimore, 1986b; Fujita et al., 1989b; Lenardo et al., 1989; 
Visvanathan and Goodbourn, 1989). In non-B and pre-B cells, NF-kB is 
associated with a cytoplasmic inhibitor (I-kB); upon induction, this complex 
dissociates to release active NF-kB which is translocated to the nucleus 
and activates transcription through interactions with its binding sites 
located in the promoters of a variety of genes (Baeuerle and Baltimore, 
1988a, 1988b). Release of NF-kB from I-kB is insufficient to activate 
transcription of the IFN-p gene, as shown by the fact that although LPS and 
PMA greatly stimulate NF-kB binding, they do not cause induction of the 
IFN-p gene (Lenardo et al., 1989). Although it seems likely that IFN-p gene 
expression is at least in part regulated by the binding of NF-kB to PRDII, it 
appears that a second signal, mediated by either virus or dsRNA but not 
LPS or PMA, is required; either the release of repression mediated by 
NRDI and/or the presence of IRF-1.
1.17 Outline of the work described in this thesis.
When I started this work it was well established that the induction of the 
IFN genes was the result of the activation of transcription (Ohno and 
Taniguchi, 1983; Raj and Pitha, 1983; Weidle and Weissmann, 1983) and 
that short 5'-flanking sequences (the VRE elements) were responsible for 
mediating this effect on the IFN genes (Dinter et al., 1983; Zinn et al., 1983; 
Fujita et al., 1985; Goodbourn et al., 1985; Ryals et al., 1985). Although the 
virus responsive element of the IFN-a1 gene had been identified (Ryals et 
al., 1985), nothing was known about factors interacting with this region that 
mediates virus inducibility upon the IFN-a1 gene. The aim of this work was 
to characterize the sequences contained within the VREal with regard to 
their transcriptional activity and factor binding potential, in the belief that
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such an approach may ultimately lead to the eventual elucidation of the 
molecular mechanism of induction of the IFN genes.
Tetramers of GAAAGT or AAGTGA, motifs present in the IFN-a1 and -p 
promoters respectively, confer virus inducibility upon a minimal promoter 
(Fujita et al., 1987; Kuhl et al., 1987). Furthermore, sequences of the type 
GAAANN are inordinately frequent in the promoters of the IFN and 
IFN-inducible genes and have been postulated to play a role in the 
induction of these genes (Hug et al., 1988). Consequently a study of the in 
vivo and factor-binding activities of tetramers of all the GAAANN variants 
present in the VREal and Mx promoters was made in the hope that an 
investigation of these elements would lead to a better understanding of the 
induction of the IFN genes. Three distinct types of (GAAANN)4 sequences, 
all of which mediated virus inducibility were identified and found to bind 
different nuclear proteins as judged by gel retardation analysis, indicating 
that potentially more than one pathway is be involved in the virus induction 
of the IFN and IFN-inducible genes.
In addition preliminary studies were undertaken to investigate the control 
of the differential regulation of the IFN-a1 gene in Hela cells. The 
expression of the endogenous IFN-a1 gene and a transiently introduced 
plasmid-borne reporter gene under the control IFN promoter elements was 
studied and evidence obtained suggesting that the endogenous IFN-a1 
gene in Hela cells is under negative control, which the reporter gene is 
some how able to evade.
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2. RESULTS.
2.1 Control of lFN-a1 expression in Hela cells.
Under normal conditions cells produce little or no IFN but upon infection 
by virus the IFN genes are expressed differentially to produce a mixture of 
IFN-a and/or IFN-p mRNA and protein. (Stewart, 1979; Lengyel, 1982). 
Hiscott et al. (1984a) showed that Hela cells treated with NDV expressed 
exclusively IFN-p mRNA; no IFN-a transcripts were detected. In order to 
investigate the inability of HeLa cells to express the IFN-a genes following 
viral infection, HeLa cells were transiently transfected with plasmids 
containing a rabbit p-globin gene under the control of either a minimal p- 
globin promoter (ID1, Figure 2) or a hybrid human IFN-a1/p-globin 
promoter, which contained two copies of VREal (13P, Figure 2).
The rabbit p-globin gene when truncated to position -56 (such that it 
retains the TATA box but no other functional elements) is neither 
constitutively active nor virus inducible (Dierks et al., 1983; Ryals et al., 
1985). When placed at position -56 of the p-globin promoter, two copies of 
the 46-bp VREal do not affect its constitutive expression, however they do 
confer virus inducibility on the downstream p-globin promoter in L929 cells 
(Kuhl et al., 1987). The use of such a gene made it possible to ascertain 
whether the IFN-a1 promoter sequences identified as being sufficient to 
mediate full induction by virus were functional in Hela cells or whether the 
block in transcription of .the endogenous IFN-a genes was occurring at 
some other point.
2.1.1 An exogenous human IFN-a1 promoter fragment, but 
not the endogenous IFN-a1 gene is virus inducible in 
Hela cells.
Hela cells were transiently transfected with the test plasmids, using the 
calcium phosphate method (Wigleret al., 1978). 48 hours after transfection 
the cells were either NDV or mock induced and 8 hours later total RNA was 
isolated. The amount of p-globin and human IFN-a1 mRNA in the 
transfected cells was determined by S1 nuclease analysis using 
appropriate 5'-32P-labeled complementary probes.
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-135 -56
-425 ]— CZh ID1
- 5 6
13P
pBR322 (VREal )x2 . TATA Exon 1 Exon 2 Exon 3 .
------------------------s / ------------------------ 1
rabbit p-globin reporter gene
Figure 2 Map of the rabbit p-globin expression plasmids used to
transfect HeLa cells.
Both ID1 and 13P are described in detail elsewhere (Ryals et al., 1985 and Kuhl et al., 
1987). In brief, rabbit p-globin sequences from -425 to +1646, which contain a deletion 
from -135 to -56 were cloned into pBR2670 (a derivative of pBR322 lacking the sequences 
between positions 656 and 2346) to generate ID1. 13P was created by cloning p-globin 
sequences from -56 to +1646 downstream of two copies of the V R E al (human IFN-a1 
gene -109 to -64) in pBR2670.
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p-globin transcripts were assayed by S1 analysis using as a probe a 
5 '-32P-labeled 452-bp Pstl-BamHI fragment of the p-globin gene from 
which the first intron had been excised (Weber et al., 1981). Correctly 
initiated p-globin transcripts gave a signal of 353 nt (Figure 3 and Ryals et 
al., 1985).
In the absence of viral induction, no signals were detected with any of 
the constructs (Figure 5A). Upon induction by virus, a signal of 353 nt was 
observed with RNA isolated from Hela cells transfected with 13P, indicative 
of correctly initiated and spliced p-globin transcripts (Figure 3; Ryals et al., 
1985). No p-globin mRNA was detected in the RNA isolated from ID1 or 
mock-transfected cells after induction by virus.
To confirm that the endogenous IFN-a1 gene was not expressed in Hela 
cells, even after induction by virus, as previously observed by Hiscott et al. 
(1984a), samples of RNA isolated from 13P transfected cells (NDV and 
mock induced) were assayed for IFN-a1 specific mRNA by S1 mapping. 
Using a 5’-32P-labeled 360-bp EcoRI-Rsal fragment of the human IFN-a1 
gene as probe (Figure 4), the 3'-ends of IFN-a1 transcripts were S1 
mapped. A probe complementary to sequences in the 3'-non-translated 
region of the IFN-a1 transcripts was chosen as this region displays the 
greatest sequence divergence with the other IFN-a transcripts (Henco et 
al., 1985) and as such does not cross-hybridize with transcripts derived 
from any of the other IFN-a genes (Streuli, 1986). Due to the heterogeneity 
of the 3' end of the IFN-a1 mRNA caused by multiple polyadenylation sites, 
protected fragments of 264, 314 and 360 nt would be indicative of human 
IFN-a1 mRNA (Figure 4; Mantei and Weissmann, 1982). None of these 
predicted IFN-a1 specific S1-resistant fragments were detected (Figure 
5B). Although 0.1 fmol (equivalent to -60 strands/cell) of an SP6 IFN-a1 
RNA transcript (gift from M. Streuli) was readily detected after exposure of 
the gel to film at -70°C with an intensifying screen for 36 hours, no signals 
were detected from the Hela cell RNA even after exposure for 30 days (data 
not shown).
This result shows that while IFN-a1 promoter elements are virus 
inducible in Hela cells when introduced on a transiently transfected 
plasmid, the endogenous IFN-a1 gene in the same cells is not expressed. 
This finding implies that the differential expression of the IFN genes in Hela 
cells is, at least in part, due to some form of negative regulation of the
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-10 0 BamH1
I I 353 nt
I I I
4  >408 nt
I V 4 1  310 nt
V O-n
209 nt
V I 452 nt
Figure 3 Schematic representation of the S1 mapping of p-globin 
transcripts (adapted from Kuhl et al., 1987).
(I) Rabbit p-globin gene: empty boxes, exons; lines between two boxes, introns. (II) Test 
RNA hybridized to the 5 '-32P-labeled (•) probe. (Ill) Hybrid between probe and correctly 
spliced transcripts initiated upstream of promoter; the length of the protected probe 
depends on the position of the 5 ' end point of the globin promoter segment. (IV) Hybrid 
between probe and transcripts which originated upstream of the promoter and were spliced 
to position +48 of the first globin exon (Ryals et al., 1987). (V) Hybrid of probe and unspliced 
RNA. (VI) The probe was a Pstl-BamHI 452-bp fragment, 5 '-32P-labeled at the BamHI site, 
derived from a p-globin genomic DNA fragment from which the small intron had been deleted 
(Weber et al., 1981). In all cases the fragment of the probe protected after S1 digestion is 
shown by thick lines.
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, - A
+ 1
EcoRI 
1 1 -
PA pA Rsal PA
▼ f  . ▼
I I 360 nt
I I I  AAAAA
264 nt ...............
■AAAAA
314 nt
■AAAAA
360 nt
Figure 4 Schematic representation of 3'-S1 mapping of the
endogenous IFN-a1 transcripts.
(I) IFN-a1 gene: coding region boxed; pA, polyadenylation sites. (II) The probe was an 
EcoRI-Rsal 360-bp fragment, 5 '-32P-labeled (•) at the EcoRI site, derived from a human IFN- 
oc1 genomic DNA fragment. (Ill) Test RNA hybridizing to the 5 '-32P-labeled probe would 
result in protected fragments of the indicated size, depending on the polyadenylation site 
utilized. In all cases the fragment of the probe protected after S1 digestion is shown by thick 
lines.
31
(3 -globin Mock
siandards 1 3 P I D1 transfected
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•587
540
504
458
'434
-267
-234
■213
.1 92 
-1 84
,1 24
k1 23
Figure 5A An exogenous human IFN-a1 promoter fragment, but not 
the endogenous gene, is virus inducible in Hela cells.
Hela cells were NDV or mock induced 48 hours after transfection with 10 p.g of test plasmid 
(or with H20 ; mock transfection). Total RNA was recovered after 8 hours induction and 16 jig 
(12.5 p,g in the case of ID1, mock induced) were S1 mapped using either an IFN-a1 or p- 
globin 5 '-32P-labeled probe.
(A) Autoradiogram of S1 mapping a using p-globin probe, after 60 hours at -70 °C with an 
intensifying screen. M, pBR322 digested with Bspl and 5 '-32P-labeled; P, probe; V, NDV 
induction; O, mock induction; p-globin standards, p-globin RNA (in pg); T, test signal.
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IFN-<x1 IFN-a1 
RNA 13P RNA 
i ii ii 1
M P 0.1 1 V O 1 0.1 P M
Figure 5B An exogenous human IFN-a1 promoter fragment, but not 
the endogenous gene, is virus inducible in Hela cells.
(B) Autoradiogram of S1 mapping using human a IFN-a1 probe, after 36 hours at -70 °C 
with an intensifying screen.
Experimental procedures and abbreviations as in Figure 5A. IFN-a1 RNA, SP6 transcripts of 
human IFN-a1 gene (in fmol); S, signal obtained from SP6 IFN-a1 transcript (Streuli, 1986).
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endogenous IFN-a1 gene, which the plasmid-borne IFN-a1/p-globin hybrid 
gene is not subject to.
A variety of mechanisms can be proposed to explain such a repression 
of the IFN-a1 gene (see Section 3.1). However, inactivation of the 
endogenous gene due to a deletion or rearrangement cannot be ruled out 
as an explanation for this phenomenon.
2.2 Tetrameric oligonucleotides of the type GAAANN mediate 
different patterns of inducibility by virus and IFN.
A large number of virus and IFN-inducible genes have been isolated 
from a variety of organisms (Revel and Chebath, 1986; Weissmann and 
Weber, 1986; and references therein), and their 5'-flanking regions have 
been shown to be required for inducibility (Friedman and Stark, 1985; and 
references therein). Sequences of the type GAAANN are inordinately 
frequent within these promoters (Table 1) and have been postulated to play 
a central role in the induction of these genes (Hug et al., 1988). Tetramers 
of AAGTGA and GAAAGT (a permutation of AAGTGA) confer virus 
inducibility on a downstream reporter gene (Fujita et al., 1987; Kuhl et al.,
1987). In this study, tetramers of all the GAAANN variants found in the 
VREal and in the Mx promoter (with the exception of GAAAAA; Figure 6), 
were examined with regard to their transcriptional activities in vivo.
The effect on transcription of oligonucleotides of the type (GAAANN)4 
(abbreviated NN4; for example GT4 for (GAAAGT)4) and of natural IFN 
promoter fragments was determined by measuring the steady state level of 
stable reporter transcripts using quantitative S1 analysis. The 
oligonucleotides to be tested were synthesized chemically with Clal and 
Hindlll-compatible overhanging ends, to allow their cloning between the 
Clal and Hindlll sites 56 bp upstream of the p-globin cap site, as shown in 
Figure 7.
The oligonucleotides were cloned into p-globin expression vectors, with 
and without the SV40 enhancer. When present, the SV40 enhancer was 
1291 bp upstream of the site into which the the oligonucleotides were 
inserted, separated by an 'inert' DNA fragment derived from the 5' flanking
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Gene Sequence Position Reference
Human IFN-a1 a GAAACA -135 to -130 Nagata et al.
GAAAGC -96 to -95 (1980b)
GAAATG -85 to -80
GAAAGT -79 to -74
GAAAGT -56 to -51
GAAATC -49 to -44
Murine IFN-a4 3 GAAAGT -97 to -92 Raj et al.
GAAAAG -91 to -87 (1989)
GAAAGC -79 to -74
Human IFN-p a GAAACT -117 to -112 Ohno and Taniguchi
GAAAAC -90 to -85 (1981)
GAAAGG -83 to -78
GAAAGT -70 to -65
GAAATT -62 to -57
GAAAGG -6 to -1
Murine Mx b GAAACTd -126 to -131 Hug et al.
GAAACGd -121 to -126 (1988)
GAAAGGd -109 to -114
GAAAAAd -67 to -72
GAAACC d -59 to -64
Murine IRF-1 b GAAATCd -122 to -127 Miyamoto et al.
GAAATG -118 to -113 (1988)
GAAATCd -21 to -26
Human 1FI-54K b GAAAAA -136 to -131 Wathelet et al.
GAAAAA -129 to -124 (1988)
GAAATTd -107 to -113
GAAAGTd -100 to -105
GAAACTd -94 to -99
GAAAGTd -88 to -93
GAAACA -64 to -59
Human IFI-56K b GAAAGTd -133 to -138 Wathelet et al.
GAAAGGd -107 to -112 (1987)
GAAACCd -100 to -105
GAAACCd -94 to -99
Human 2-5 A GAAAGG -147 to -142 Wathelet et al.
synthetase c GAAACTd -100 to -105 (1987)
GAAATT -76 to -71 -
GAAAGT -34 to -29
Human 6-16 c GAAACT -145 to -140 Porter et al.
GAAAAT -110 to -105 (1988)
GAAACT -104 to -99
GAAATA -88 to -83
GAAACT -82 to -77
a virus inducible genes b virus and IFN inducible genes
c IFN inducible genes d antisense strand
Table 1. Occurrence of GAAANN sequences within the 150-bp
preceding the cap site of virus and IFN inducible 
genes.
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Figure 7 Structure of the region into which promoter elements
were inserted.
When required, the SV40 enhancer 72 bp repeat was inserted into the EcoRI site, a 1291 
bp spacer between the Xhol site in the linker at the 3 ' end of the SV40 enhancer and the 
Clal site, and promoter elements between the Clal and Hindlll sites.
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region of the p-globin gene (Kuhl et al., 1987). Several intrinsic properties 
of the oligonucleotides were examined using these constructs; (1) 
constitutive transcriptional activity, (2) inducibility by virus and (3) 
inducibility by IFN-y.
2.2.1 The assay system.
The rabbit p-globin gene functioned as a reporter, with test sequences 
cloned at position -56 relative to the cap site (see Figure 7), while a 
thymidine kinase/glucocorticoid receptor gene under the control of the 
cytomegalovirus (CMV) promoter/enhancer served as an inducible 
reference plasmid (pSTC 407-556; Severne et al., 1988). Murine L929 
cells were transiently transfected with a mixture of the test and reference 
plasmid, in addition to either pIRF-L, an IRF-1 expression plasmid 
(Miyamoto et al., 1988) or the 'empty' expression vector, CDM8 (Seed,
1988). Forty eight hours after transfection the cells were either NDV, IFN or 
mock induced, and 8 hours later total RNA was isolated.
Test p-globin transcripts were assayed as in Section 2.1.1. Transcripts 
derived from the internal reference plasmid were detected using a probe 
which generated a signal of 148 nt (Figure 8). Transcription of the 
reference, under the control of the CMV promoter/enhancer was also virus 
inducible, thus allowing corrections to be made for the efficiency of virus 
induction, as well as RNA recovery and transfection.
Radioactivity in the test and reference signals was determined by 
Cerenkov counting. Test signals were normalized relative to the 
corresponding reference signals and quantitated relative to signals given 
by known amounts of p-globin mRNA and the number of strands per cell 
was determined as in Kuhl et al. (1987).
2.2.2 Tetrameric oligonucleotides of the type (GAAANN)4 
mediate different patterns of transcriptional activity.
A 'minimal promoter' which retains a TATA box but no additional 
upstream elements, is essentially silent and requires the presence of
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S1 probe
I------------ 1
Sacl BamHI
V V  A AT AAA
vector
CMV promoter/enhancer rGR (407-556) rabbit p-globin SV40 ori
t
1  mRNA - i  Hybrid between 5' labeled (•)
167 nt — probe - i  probe and reference RNA
^  S1 nuclease digestion
148 nt
Figure 8 Schematic representation of S1 mapping of the internal
reference gene.
pSTC407-556 (Severne et al., 1988) served as an inducible internal reference, whose 
transcripts were S1 mapped using a probe prepared by 5'-labeling at the BamHI site and 
cleaving with Sacl.
vectorl
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additional elements for activity, such as a CAAT box (Dierks et al., 1983), a 
heat shock element (Bienz and Pelham, 1986) or a tetrameric repeat of 
repA (Kuhl et al., 1987). In this context, tetrameric GAAANN elements were 
assayed for their ability to mediate constitutive transcription and confer 
inducibility by virus and IFN-yon the p-globin gene.
2.2.3 The tetrameric oligonucleotides mediate inducibility by 
virus.
All of the tetramerized hexanucleotides tested, as well as both VREal 
and VRE(3, mediated induction by virus, though the transcript level and 
degree of inducibility varied greatly between the various elements. In the 
absence of the enhancer (Figure 9; V, column no IRF), CC4 exhibited the 
highest degree of inducibility, >58 fold, about 7 times greater that that of the 
next highest, GT4. The least inducible was TG4, for which the level of 
induction in the absence of the enhancer was so weak that it was not 
possible to quantitate, although inspection of the autoradiograph revealed 
weak virus induction.
2.2.4 The upstream SV40 enhancer and oligonucleotides 
interact through enhancer coupling to potentiate 
transcription.
When placed 1300 bp upstream of the TATA box of a minimal promoter, 
the SV40 enhancer is unable to activate transcription in the absence of an 
appropriate upstream element placed close to the TATA box (Pelham, 
1982; Hen et al., 1982; Treisman and Maniatis, 1985; Kuhl et al., 1987). 
The ability of an upstream enhancer to exercise its effect upon a minimal 
promoter was termed enhancer coupling, and is expressed as the ratio of 
transcript level obtained in the presence of an enhancer at distance (Figure 
10) to that obtained with the oligonucleotide alone (Figure 9), in either the 
uninduced or induced state.
In the absence of induction, only CG4, VREal and VREp showed 
enhancer coupling (because these were the only elements mediating some 
degree of constitutive transcription; Figure 11). Upon viral induction, all of
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NONE (GAAAGT)4 (GAAACC)4 
no IRF with IRF no IRF with IRF no IRF with IRF
I II II II 1 I II 1
M P 0 V 0 V 0 V 0 V 0 V  0 V PM
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Figure 9A Activation of transcription by NDV and/or cotransfection
with IRF-1 expression plasmid mediated by various 
oligonucleotides (without SV40 enhancer).
Mouse L929 cells were transfected with 7 fig each of the test and reference plasmids, and 
with 7 pg of either the IRF-1 expression plasmid pIRF-L ('with IRF') or the corresponding 
'empty' expression vector CDM8 ('no IRF'). Induction with NDV or mock induction were 
carried out 48 hours after transfection. Total RNA was recovered 8 hours after beginning of 
induction and 50 pg were S1 mapped simultaneously with the probes for the reporter and 
the internal control.
(A)-(C) Autoradiograms of S1 mapping after 5 days at -70°C with an intensifying screen. 0, 
mock induction; V, NDV induction; globin standards, globin RNA (in pg); M, pBR322 
digested with Bspl and 5 '-32P-labeled; I, aberrantly spliced readthrough p-globin transcripts; 
P, probes; P r, undigested reference probe; Pj,  undigested test probe; R, signal from the 
reference gene; T, test signal; U, readthrough p-globin transcripts (see F ig .lD , Kuhl et al., 
1987). Results summarized in Figure 9D.
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Figure 9B Activation of transcription by NDV and/or cotransfection 
with IRF-1 expression plasmid mediated by various 
oligonucleotides (without SV40 enhancer).
Autoradiogram of S1 mapping after 5 days at -70 °C with an intensifying screen. 
Experimental procedures and abbreviations as in Figure 9A. Results summarized in Figure 
9D.
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VREal VREp
globin
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Figure 9C Activation of transcription by NDV and/or cotransfection 
with IRF-1 expression plasmid mediated by various 
oligonucleotides (without SV40 enhancer).
Autoradiogram of S1 mapping after 5 days at -70 °C  with an intensifying screen. 
Experimental procedures and abbreviations as in Figure 9A. Results summarized in Figure 
9D.
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NONE
no IRF with IRF
I------------ 1-I------- 1
MP Y 0 V 0 V PM
T
R • • f i t
Figure 10A Induction of transcription by NDV, IFN-y and/or by
cotransfection with IRF-1 expression plasmid mediated 
by different oligonucleotides (with SV40 enhancer at a 
distance).
Autoradiogram of S1 mapping after 15 hours at -70 °C with an intensifying screen. 
Experimental procedures and abbreviations as in Figure 9A. Induction with rat IFN-y (1000 
units/ml) was carried out 48 hours after transfection, y, IFN-y induction. Results summarized 
in Figure 10G.
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(GAAAGT)4 (GAAACC)4 (GAAACG)4
no IRF with IRF no IRF with IRF no IRF with IRF
i------------ 11------- 11------------1 r — i i 11------- 1
M P  Y O V O V Y  O V O V  O Y V  O V M
pr
T
p r -
Figure 10B Induction of transcription by NDV, IFN-y and/or by
cotransfection with IRF-1 expression plasmid mediated 
by different oligonucleotides (with SV40 enhancer at a 
distance).
Autoradiogram of S1 mapping after 15 hours at -70 °C  with an intensifying screen.
Experimental procedures and abbreviations as in Figure 10A. Results summarized in Figure
10G.
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(GAAACT)4 (GAAAGG)4
globin
no IRF with IRF no IRF with IRF standards
i 11— 11----------- 11— 11 i
M P T  0 V 0  V T 0 V 0  V 50 100 300 P M
Figure 10C Induction of transcription by NDV, IFN-y and/or by
cotransfection with IRF-1 expression plasmid mediated 
by different oligonucleotides (with SV40 enhancer at a 
distance).
Autoradiogram of S1 mapping after 15 hours at -70 °C  with an intensifying screen.
Experimental procedures and abbreviations as in Figure 10A. Results summarized in Figure
10G.
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(GAAAGT)4 (GAAATG)4 (GAAAGC)4
no IRF with IRF no IRF with IRF no IRF with IRF
i r i 1 i i i  1 i 11------- 1
M P Y  O V O V Y  O V O V Y  O V Q  V P M
Figure 10D Induction of transcription by NDV, IFN-y and/or by
cotransfection with IRF-1 expression plasmid mediated 
by different oligonucleotides (with SV40 enhancer at a 
distance).
Autoradiogram of S1 mapping after 15 hours at -70 °C  with an intensifying screen.
Experimental procedures and abbreviations as in Figure 10A. Results summarized in Figure
10G.
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(GACAGT)4 VREal
globin
no IRF with IRF no IRF with IRF standards
I-------------1-I------- 1 I------------1-I------- 1 I-------------1
M P T  0 V 0 V T 0 V 0 V 50 100 300 P M
Figure 10E Induction of transcription by NDV, IFN-y and/or by
cotransfection with IRF-1 expression plasmid mediated 
by different oligonucleotides (with SV40 enhancer at a 
distance).
Autoradiogram of S1 mapping after 15 hours at -70 °C  with an intensifying screen.
Experimental procedures and abbreviations as in Figure 10A. Results summarized in Figure
10G.
49
VREp
globin
no IRF with IRF standards
I II I I------------1
0 V 0 V P M 50 100300PM
4
•  •  A
R ♦ft#
Figure 10F Induction of transcription by NDV, IFN-y and/or by
cotransfection with IRF-1 expression plasmid mediated 
by different oligonucleotides (with SV40 enhancer at a 
distance).
Autoradiogram of S1 mapping after 5 days at -70 °C with an intensifying screen (from a 
separate experiment to that shown in Figures 10A-E). Experimental procedures and 
abbreviations as in Figure 10A. Results summarized in Figure 10G.
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INSERT UNINDUCED INDUCED
'in e rt' spacer
(GAAAGT)4 - 16
(GAAAGC)4 N D N D
(GAAACT)4 N D N D
(GAAACC)4 - 2.4
(GAAATG)4 - >70
(GAAACG)4 9 15
(GAAAGG)4 - 42
VREal >4.4 18
VREp >2 22
Figure 11. The upstream SV40 enhancer and oligonucleotides 
interact through enhancer coupling to potentiate 
transcription.
Enhancer coupling is the ratio of transcripts given by an oligonucleotide preceded by an 
enhancer at a distance (Figure 10) to that given by the oligonucleotide alone (Figure 9). ’ND \
not determined; not measurable.
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the oligonucleotides displayed some degree of enhancer coupling. 
Tetrameric TG4 exhibited the highest degree of induced enhancer 
coupling, >70 fold. GG4 the next highest, displayed a 42 fold stimulation of 
transcription in the presence of the enhancer, VREal and VREp 
approximately 20 fold, CG4 and GT4, 15 fold and CC4, 2.4 fold. The low 
degree of induced enhancer coupling seen with CC4 was detectably higher 
than that of the 'inert' spacer control, for which no enhancer coupling was 
observed.
2.2.5 GT4,G C 4, CT4, CC4 and GG4 are all inducible by IFN-y.
In addition to being inducible by virus, the majority of the tetrameric 
hexanucleotides tested were found to be inducible with IFN-y (Figure 10; y, 
column no IRF), albeit at a reduced level. In the presence of the upstream 
enhancer, all of the hexanucleotide repeats with the exception of TG4 and 
CG4 displayed inducibility in response to IFN-y, at levels between >3 and 
>28 fold. Of the natural IFN promoter segments, only VREal was tested 
and transcription from this element was found to be essentially unaffected 
in the presence of IFN-y.
2.2.6 Only CG4 displays constitutive activity.
With the exception of CG4i all of the tetrameric hexanucleotides tested 
lack constitutive transcriptional activity, both in the presence and absence 
of the SV40 enhancer (Figure 10 and 9; 0, column no IRF). Constitutive 
transcription mediated by the CG4 oligonucleotide in the absence of the 
upstream SV40 enhancer is marginally (>2 fold) above the background 
levels; the presence of the enhancer stimulated transcription 9 fold.
Although the increase observed in transcription in the presence of the 
enhancer can be attributed, in part, to the 2 fold stimulation obtained when 
the SV40 enhancer is 1300 bp upstream of the minimal promoter, (Kuhl et 
al., 1987), this does not completely account for the activation. It is possible 
that some part of this increase is due to enhancer coupling, as discussed in 
Section 2.2.4.
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2.2.7 GT4, GC4, CT4, CC4, and GG4 all mediate activation by 
IRF-1.
Taniguchi and co-workers identified and cloned the cDNA encoding 
Interferon Regulatory Factor 1 (IRF-1), the level of which is increased after 
virus induction and which has been implicated as having a role in the 
induction of the IFN genes (Fujita et al., 1988; Miyamoto et al., 1988). 
Introduction of an IRF-1 expression plasmid by transient transfection into 
cos cells leads to the expression of the previously silent endogenous IFN-a 
and p genes, in the absence of viral stimulation (Fujita et al., 1989a).
IRF-1 binds to (AAGTGA)4 (a permutation of GT4; Fujita et al., 1988) and 
it was of course of great interest to determine which, if any, of the virus 
inducible (GAAANN)4 elements could be activated by IRF-1. To this end, an 
expression plasmid containing the IRF-1 gene under the control of the CMV 
promoter/enhancer (pIRF-L; Miyamoto et al., 1988) was co-transfected with 
a reporter plasmid containing a tetrameric oligonucleotide preceded by the 
SV40 enhancer at a distance.
Cotransfection with pIRF-L stimulated the transcription of GT4, GC4, CT4 
and CC4 over 20 fold, to levels approximately 3 to 5 times lower than those 
obtained by virus induction alone (Figure 10; 0, column with IRF). Of the 
remaining tetrameric hexanucleotides tested, only GG4 showed any 
significant activation by IRF-1 (>9 fold). CG4 and TG4 were unaffected by 
cotransfection with pIRF-L, although both were efficiently induced by virus.
Cotransfection with IRF-1 stimulated transcription from VREp only 2.7 
fold and VREal not at all. The failure of pIRF-L to transactivate VREal was 
surprising in view of the findings of Fujita et al. (1989a) that both the 
endogenous IFN-a and -p genes were activated by the transfection of an 
IRF-1 expression plasmid into cos cells. The apparent discrepancy 
between these results may be the consequence of pIRF-L replicating to a 
high copy number in cos cells (which contain the SV40 T antigen) but not in 
L929 cells (which lack the SV40 T antigen; Lusky and Botchan, 1981). 
Amplification of the IRF-1 expression plasmid in cos cells could result in 
more efficient expression of IRF-1, such that it reaches a level sufficient to 
activate transcription.
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Cotransfection of L929 cells with pIRF-L and plasmids containing GT4> 
GC4, CT4 or CC4, followed by virus induction (Figure 10; V, column with 
IRF) led to a 1.5 to 2 fold stimulation of transcription above that obtained 
following virus induction alone (Figure 10; V, column no IRF). Virus 
induction of cells cotransfected with pIRF-L and plasmids containing either 
CG4 and TG4j (Figure 10; V, column with IRF) gave transcript levels equal 
to or lower than those obtained with NDV induction alone (Figure 10; V, 
column no IRF).
The results obtained in the absence of an enhancer were in general 
agreement with those obtained in the presence of an enhancer, although 
as expected the transcription levels were lower (Figure 9; V, column with 
IRF). However, for GT4, IRF-1 stimulation of transcription was greater than 
that obtained after induction by virus. In the absence of an enhancer, 
transcript levels derived from the GT4 element were 1.25 fold higher after 
IRF-1 transactivation (Figure 9; 0, column with IRF) than after virus induction 
(Figure 9; V, column no IRF). This was in contrast to the finding when the 
SV40 enhancer was present, in which case 3 times more p-globin 
transcripts were detected after induction by virus (Figure 10; V, column no 
IRF) than after transactivation by IRF-1 (Figure 10; 0, column with IRF). 
Unlike GT4, all other oligonucleotides tested exhibited higher levels of 
transcription after induction by virus (Figure 9; V, column no IRF) than after 
transactivation by IRF-1 (Figure 9; 0, column with IRF).
When pIRF-L and GT4 plasmids were cotransfected and the cells treated 
with virus (Figure 9; V, column with IRF), stimulation of transcription was 3.5 
fold higher than with virus induction alone and resulted in a transcript level 
higher than the sum of the transcripts obtained after induction by virus 
(Figure 9; V, column no IRF) and transactivation by IRF-1 (Figure 9; 0, 
column with IRF). Similar, though less pronounced, IRF-1-mediated 
stimulation of virus-induced transcription was seen with GC4, CT4, CC4 and 
GG4 both in the presence and absence of the enhancer (when tested).
The apparent synergistic stimulation of virus-induced transcription 
mediated by cotransfection of pIRF-L can probably be attributed to 
increased expression of IRF-1, brought about by virtue of the virus 
inducibility of the CMV promoter/enhancer (Kuhl et al., 1987) which directs 
expression of pIRF-L.
55
Thus, it appears that while all of the NN4 elements tested and both 
VREal and VRE(3 are virus-inducible, only some are activated by IRF-1 
(GT4, GC4, CT4> CC4, GG4 and VREp). This indicates that a pathway(s) 
other than that involving IRF-1 may be involved in the viral induction of 
elements not activated by IRF-1 (TG4> CG4 and VREal). Thus, the 
observation that VREp is weakly stimulated in the presence of IRF-1 while 
the transcriptional activity of VREal is unaffected indicates that these two 
genes may be induced by different pathways.
2.2.8 Tetrameric oligonucleotides mediating inducibility by 
virus are of distinct types.
The (GAAANN)4 elements were categorized into three groups based on 
the effect they had on transcription:
Type I oligonucleotides: Oligonucleotides of this type show no 
constitutive expression, are strongly inducible by virus, display a moderate 
induction by IFN-y and IRF-1. This group includes GT4, GC4, CT4 and CC4 
(see Table 2)
Type II oligonucleotides: The sole representative of this group identified 
to date is TG4, which differs from those of type I by the criterion that it fails to 
respond to both IFN-y and IRF-1. As type I, the type II oligonucleotide 
displays no constitutive expression and is inducible by virus.
Type III oligonucleotides: The distinguishing characteristic of type III 
oligonucleotides, which are represented by CG4, is their high constitutive 
expression. Type III oligonucleotides are moderately inducible by virus but 
display no inducibility by IFN-y or IRF-1.
The behavior of GG4 was found to be intermediate, in that in some 
experiments it displayed weak constitutive transcription, a characteristic 
associated with type III oligonucleotides, while at the same time was 
inducible by IFN-y and IRF-1, indicating that it shared properties with type I 
oligonucleotides.
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constitutive virus IFN IRF-1
activity_________ induction________ induction________ response
Type I
(GAAAGT)4 +  +  +
(GAAAGC)4 +  +  +
(GAAACC)4 +  +  +
(GAAACT)4 -  +  +  +
Type II
(GAAATG)4 +  -  -
Type III
(GAAACG)4 +  +
Type I/Type III
(GAAAGG)4 + /“ + + +
Virus Responsive 
Elements
V R E a l  “  +
V R E p  +  ( + )
Table 2 Properties of tetrameric hexanucleotides of the type
(GAAANN)4 and of virus responsive elements.
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2.3 Interactions between nuclear proteins and the 
(GAAAGT)4 and VREal motifs.
The binding of nuclear factors from virus-induced and uninduced 
Namalwa cells to GT4 and VREal was studied using gel retardation 
analysis (Fried and Crothers, 1981; Garner and Revzin, 1981). To 
determine the specificity of the protein-oligonucleotide interactions, 
competition experiments were performed by mixing labeled oligonucleotide 
with various amounts of an unlabeled one prior to incubation with nuclear 
extract. The resulting complexes were resolved by electrophoresis through 
non-denaturing polyacrylamide gels and visualized by autoradiography.
2.3.1 Evidence for a common factor(s) binding to type I 
tetrameric oligonucleotides.
Incubation of 5'-32P-labeled GT4 with uninduced Namalwa nuclear 
extract resulted in the formation of 3 retarded complexes (Figure 12). 
Competition with an excess of unlabeled competitor oligonucleotide 
revealed that only type I oligonucleotides (namely GT4, GC4, CT4 and CC4) 
efficiently displaced the 3 retarded bands. At a 25 fold molar excess of the 
type I oligonucleotides a reduction of approximately 50% in the intensities 
of the retarded bands was obtained (as judged by inspection of the 
autoradiogram) and at a 625 fold molar excess the retarded bands had 
essentially disappeared (Figure 12).
Of the other oligonucleotides tested, only VREp competed significantly. 
Approximately a 5 fold higher molar excess of VREp competitor was 
required to compete the GT4 band shift to an equivalent degree as of the 
type I oligonucleotide competitors (Figure 12). None of the other 
oligonucleotides tested (VREal, CG4, GG4, TG4 or (GACAGT)4) competed 
the GT4 band shift efficiently. Generally, levels of competition at least 100 
times higher than those required with type I oligonucleotides were needed 
to obtain similar levels of competition (Figure 12).
In conclusion, these findings imply that the type I oligonucleotides bind 
one or more common factor(s) with more or less equal affinity. With the 
exception of VREp, which has a weak affinity for these factors, none of the 
other elements tested, in particular VREal, appeared to specifically bind
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the type 1 oligonucleotide binding factor(s). It is not known which, if any of 
the GT4 retarded bands detected using Namalwa nuclear extract 
corresponds to IRF-1 or -2.
2.3.2 VREal binding factors have affinity for TG4 but for 
none of the other NN4 elements.
At least 3 DNA/protein complexes were obtained when 32P-labeled 
VR Eal was incubated with uninduced Namalwa extract (Figure 13). 
Competition experiments similar to those done with GT4 were performed to 
ascertain which if any of the factors binding to VREal also had affinity for 
other oligonucleotides. Self competition in the VREal band shift required a 
substantially higher molar excess than did self competition in the GT4 band 
shift. At a 625 fold molar excess of VREal, approximately 50% competition 
of all the VREal bands was obtained (Figure 13), a level of competition 
achieved at a 25 fold molar excess of GT4 in the GT4 band shift (Figure 12). 
The high levels of VREal required to compete the VREal-retarded bands 
perhaps reflects the abundance of the factor(s) involved in these 
interactions or that it the factor(s) displays a low affinity for VREal (relative 
to the GT4 binding factors to GT4).
TG4 and VREp competed all 3 of the VREal retarded bands, but at 
varying efficiencies (Figure 13). The fastest migrating of the 3 retarded 
bands ('TG protein'; see Section 2.3.4) was competed about 2 to 5 and 50 
fold less well by TG4 and VREp respectively, than by an equivalent amount 
of VREal (for confirmation of this result see Section 2.3.4). In contrast, the 
intermediate band was competed better by VREp than TG4, requiring about 
5 times more VREp and 10 times more TG4 to obtain the same effect as 
VREal. TG4 competed the slowest migrating band with a similar efficiency 
as VR Eal; VREp on the other hand displayed approximately a 5 fold lower 
efficiency.
Almost no competition of the 3 VREal retarded bands was observed 
with any of the other NN4 elements, except for a general reduction in the 
intensities of the bands observed with all the tetrameric hexanucleotides at 
a 15 625 fold molar excess (Figure 13).
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It appears from these results that perhaps as many as 3 different factors 
are capable of binding to the VREal, 2 of which (the proteins involved in 
the formation of the fastest ('TG protein'; see section 2.3.4) and slowest 
migrating complexes) show a similar affinity for TG4 and VR Eal, a weaker 
affinity for VREp but no affinity for any of the other oligonucleotides. The 
third factor (involved in the formation of the complex with intermediate 
mobility) shows a roughly equal, though weak affinity for TG4 and VREp.
2.3.3 Tetrameric oligonucleotides of Type I, II and III give 
distinct gel retardation patterns.
Subsequent gel retardation analysis performed by P. Gallant (1899) 
showed that the other type I oligonucleotides GC4, CT4 and CC4 all 
generated the same pattern of 3 bands as GT4 (see Figure 12). The type II 
oligonucleotide TG4 gave a major band which did not line up with any 
given by the other NN4 oligonucleotides, and two weaker bands. Type III 
oligonucleotide CG4 also generated 3 bands, of which only one had the 
same mobility as seen in the type I pattern. GG4 gave a pattern similar to 
that of CG4.
Gel retardation competition experiments were performed (by P. Gallant) 
with various unlabeled oligonucleotides and the radioactivities in selected 
bands were quantitated (Gallant, 1989). In summary: (1) the three bands 
generated by any type I oligonucleotide were displaced efficiently by any 
member of the same type. Other oligonucleotides, such as CG4, GG4, TG4, 
AA4, or the 'mutant' (GACAGT)4 competed only at 100 to 1000 fold higher 
levels; VREp was a poor and VREal a very poor competitor. (2) With 
labeled type II oligonucleotide TG4, the bands were competed efficiently by 
TG4 and VREal but not by any other tetrameric oligonucleotide. (3) Type III 
oligonucleotide CG4 was competed 30-100 fold less well by GG4 than by 
itself, even worse by TG4 and not by any other oligonucleotide. (4) GG4 
gave a pattern similar to that of CG4, was competed efficiently by CG4, less 
well by TG4 and not by any other oligonucleotides. Thus, the 3 types of 
oligonucleotides mediating virus inducibility formed different, characteristic 
complexes.
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2.3.4 Type II oligonucleotide TG4 and VREal interact with a 
presumably novel 'TG protein'.
Further analysis of proteins interacting with TG4> performed by P. Gallant 
and D. Maguire, showed that of the 3 retarded bands one is due to the 
ubiquitous octamer factor, OTF-1 (see discussion) while another was 
competed by all competitor DNA oligonucleotides tested and was thus 
considered to be unspecific. The retarded band with highest mobility was 
competed by TG4 and VREal only. The protein giving rise to this 
interaction was designated TG protein1.
Using labeled VREal and partially purified TG protein (from A. Sailer), a 
band shift competition experiment was performed to determine the 
specificity of TG protein binding to VREal (Figure 14). TG protein binding 
was competed efficiently by VREal, about 1.8 times less well by TG4 and 
30 and >50 times less well by VREp and GT4, respectively. Thus TG protein 
binds specifically to VREal and TG4 which share the sequence 
GAAATGGAAA (positions -75 to -84 of IFN-a1 promoter)
In order to determine whether the TG protein forms similar contacts to 
sequences within TG4 and VREal, methylation interference experiments 
were performed (in collaboration with D. Maguire). Methylation interference 
is based on the fact that methylated guanine or adenine residues can 
interfere with the binding of a protein to its binding site (Siebenlist and 
Gilbert, 1980). Thus, a comparison of the distribution of methylated 
residues in DNA following separation of free and bound DNA after gel 
retardation analysis indicates which guanine and adenine residues cannot 
be modified without interfering with the formation of a DNA/protein complex.
32P-labeled TG4 and VREal were partially methylated and used in a 
scaled-up binding reaction with partially purified TG protein. A 625-fold 
excess of unlabeled GT4 (shown previously to be sufficient to compete 
binding to residual IRF-1 or IRF-2 by more than 90%) was added. The DNA 
in the protein-DNA complex (bound) and the free DNA were recovered after 
gel electrophoresis, a G>A cleavage reaction was performed, and the 
product analyzed on a denaturing polyacrylamide gel.
Figure 15 shows that the methylation of neighboring guanine residues 
(doubly underlined) in the sequence common to both oligonucleotides,
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Figure 15A TG protein makes similar contacts with the TG sequence 
of VREal and TG4.
The methylated, labeled oligonucleotides were incubated with partially purified TG protein 
(TG 4 step I and V R E al with step II preparation; see Experimental Procedures) in the 
presence of a 625 fold excess of unlabeled GT4, and bound and free oligonucleotides 
isolated after separation by gel retardation. After alkaline cleavage, the products were 
separated on sequencing gels and visualized by autoradiography. The lanes were scanned 
with a Molecular Dynamics 300A Computing Densitometer and the profiles pertaining to free 
and bound products superimposed. The black areas correspond to regions where the 
bands of free product are more intense than those of the bound product and indicate 
interference by methylation; the hatched areas show where the bound product had 
stronger bands than the free product.
(A) Autoradiogram and densitometric scanning of methylation interference performed with 
5'-32P-labeled V R E a l.
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3'- GTAA A G G T A A A  G G T  A A A G G TAAAG -5'
o  o •  •  •  •
Bound DNA
Figure 15B TG protein makes similar contacts with the TG sequence 
of VREal and TG4.
Autoradiogram and densitometric scanning of methylation interference performed with 
5’-32P-labeled TG4. Experimental procedures as in Figure 15A.
...GAAATGGAAA..., strongly interferes with the binding of the TG protein. In 
both cases weaker interference with binding was also observed when the 
preceding G was methylated (wavy underline). Consequently, it appears 
that the TG protein makes similar interactions with the sequence common 
to both TG4 and VREal.
2.3.5 Extracts prepared from virus-induced cells give the 
same band shift pattern as those prepared from 
uninduced cells.
Nuclear extracts prepared from Namalwa cells 15 min, 45 min, 2.25 hr,
4.5 hr or 9.5 hr after induction with NDV gave essentially the same pattern 
of retarded bands with either GT4 or VREal as extracts derived from 
uninduced Namalwa cells (data not shown).
2.4 Determination of the sequences required for virus 
induction of the IFN-a1 promoter in Namalwa ceils.
The inability to detect differences between induced and uninduced 
Namalwa cell nuclear extracts in the band shift assay was somewhat 
unexpected in view of the observation of specific, inducible complexes with 
the IFN-p regulatory elements (Keller and Maniatis, 1988). A possible 
explanation for this was that perhaps the elements of the human IFN-a1 
gene identified as being important for virus induction in murine L929 cells 
(Ragg and Weissmann, 1983; Ryals et al., 1985; Kuhl et al., 1987) are not 
necessarily the same as those required for the virus induction of the IFN-a1 
gene in Namalwa cells. To address this question, Namalwa cells were 
transiently transfected with p-globin expression plasmids into which had 
been inserted various IFN-a1 promoter fragments (see Figure 16C).
Namalwa cells were transiently transfected with a mixture of test and 
reference plasmids. The reference plasmid contained the p-globin gene 
under the control of VREal with a small substitution in the first exon which 
gives rise to imperfect hybridization between the probe and reference RNA 
and thus results in the correspondingly shorter S1 digestion product of 
218 nt (see Figure 1D in Kuhl et.al., 1987). 48 hours later the cells were
67
either NDV or mock induced and total RNA was isolated after a further 8 
hours. Test and reference transcripts were assayed by S1 analysis as in 
Section 2.1.1. Test signals were normalized relative to the corresponding 
reference signals, to compensate for variations in the efficiencies of 
transfection, induction and RNA recovery.
2.4.1 VREal mediates inducibility by virus in Namalwa cells.
A single copy of VREal, when joined to position -56 of the p-globin gene 
conferred weak virus inducibility (>4.4 fold, 11 strands per cell; Figure 16) 
upon the p-globin reporter gene in Namalwa cells. Dimerization of the 
VREal dramatically increased the inducibility to >94 fold (235 strands per 
cell; Figure 16). Longer IFN-a1 promoter fragments (-141 to -41, -22 or -6 
and -675 to -6) were all found to be less active than the a single copy of the 
VR Eal, giving inducibilities of between >3.2 and >2.2 fold and 5 between 8 
strands per cell (Figure 16).
These results observed with Namalwa cells were almost identical to 
those previously obtained in a similar assay system using murine L929 
cells (Kuhl et al., 1987; Bueler, 1988; Naf, 1989), suggesting that the 
mechanisms that govern virus inducibility in L929 cells are similar to those 
in Namalwa cells.
A promoter consisting of GT4 supported by the SV40 enhancer 28 bp 
upstream (enhancer close-by) was also inducible in Namalwa cells and 
gave the highest level of induced transcripts of any of the constructs tested 
(350 strands per cell), 1.5 times more than dimerized VREal (Figure 16). 
However, because of the high constitutive expression of the GT4 construct 
due to the close-by enhancer (60 strands per cell), the level of inducibility 
was lower (Figure .16).
The only discrepancy between the results obtained in Namalwa and 
L929 cells was seen with the GT4 construct, which in L929 cells was silent 
in the absence of viral induction (<2.5 strands per cell; Naf, 1989 1), but in 
Namalwa cells showed strong constitutive activity. The constitutive activity 
of the GT4 construct in Namalwa cells may be due to the proximity of the
1 The number of strands per cell calculated in Naf (1989) was over-estimated by a factor 
of 2 and this has been corrected for in the values quoted In this work.
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globin
standards ID1 (GAAAGT)4 V R E a l 2xVREa1
M P §  §  £  0 V O V  0 V O V  P M
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Figure 16A V R E a l  mediates inducibility by virus in 
Namalwa cells.
(A)-(B) Autoradiogram of S1 mapping after 38 hours at -70 °C with an intensifying screen. 
Namalwa cells were transfected with 2.5 pig of each of the test and reference plasmids and 
48 hours later either mock or NDV induced. Total RNA was recovered after a further 8 hours 
and 50 pg were S1 mapped. Abbreviations as in Figure 9A; GT4, plasmid 61P; V R E a l; 
plasmid 12P; 2xVREa1, plasmid 13P. Schematic representation of the plasmids used in 
this experiment and a summary of the results can be found in Figure 16C.
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globin
standards -141/-41 -141/-22 -141/-6 -625/-6
r ^ ~ i  i 1 i 1 i 1 i 1
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Figure 16B V R E a l  mediates inducibility by virus in 
Namalwa cells.
Autoradiogram of S1 mapping after 38 hours at -70 °C with an intensifying screen. 
Experimental procedures as in Figure 16A. Abbreviations as in Figure 9A; -141/-41, plasmid 
CF2/42P; -141/-22; plasmid CF1/42P; -141/-6, plasmid R(3Ga-141/-6; -625/-6, plasmid pIG. 
Schematic representation of the plasmids used in this experiment and a summary of the 
results can be found in Figure 16C.
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ID1
TR A N SC R IPT LEVEL
(strands per cell)
Uninduced Induced
-13^56
< 2.5 < 2.5
Inducibility
61P
- - -S S H S H S -IZ H Z H Z ]—
g t 4
60
12P
-109 -64
VREal
< 2.5
350
11
5.8 fold
>4.4 fold
13P
2x VREal
< 2.5 235 >94 fold
CF2/42P
< 2.5 6.5 >2 .6  fold
CF1/42P
-141 -►-22
< 2.5 8 >3.2 fold
RPG a-141/-6 
-141 -►  -6
< 2.5 >2  fold
<2.5 >2 .8  fold
—  E3 S3 nm w f t m
GT4 TATA Exon 1 Exon 2 Exon3
pBR SV40 (GAAAGT)4 V R E a l IFN -a l I------------------- .  I
enhancer promoter
Rabbit Globin gene
Figure 16C V R E a l mediates inducibility by virus in 
Namalwa cells.
Summary of the S1 mapping experiments depicted in Figures 16A-B. Transcript levels were 
calculated as described in Kuhl et al. (1987). Experimental procedures as in Figure 16A.
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enhancer to the TATA box. A level of 45 strands per cell was found with 
H-ES in L929 cells (Naf, 1989 1), a plasmid in which the GT4 element has 
been replaced with an inert spacer. In L929 cells, the GT4 element reduces 
the level of constitutive transcription by >20 fold (Naf, 1989) as a 
consequence of reversible suppression of the constitutive activity of the 
SV40 enhancer (’silencing1; Kuhl et al., 1987).
The differences in the constitutive activity displayed by GT4 with the 
enhancer close by in Namalwa and L929 cells could be due to either the 
absence of silencing in Namalwa cells, an increased activity of the SV40 
enhancer when placed 82 bp upstream of the of the TATA box in Namalwa 
cells as compared to L929 cells or a combination of both. Since the effect 
the SV40 enhancer has on constitutive transcription in Namalwa cells 
when in this position is not known, it is not possible to differentiate between 
these two possibilities.
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3. DISCUSSION.
The IFN genes provide a particularly interesting, if complex model for the 
study of the regulation of transcription, being expressed in an inducible and 
tissue-specific manner. In addition, the individual IFN gene transcripts are 
subject to differential rather than coordinate regulation.
3.1 Control of the differential expression of the IFN genes.
Hiscott et al. (1984a, 1984b) suggested that the differences in the levels 
of the individual IFN transcripts in different cell types could be a result of a 
number of mechanisms: (1) there could be several pathways of induction, 
one of which would be prevalent in a particular cell type, (2 ) there could be 
cell specific differences in the degradation rate or translation of individual 
IFN mRNAs or (3) the induction of the individual IFN genes could as a 
consequence of tissue-specificity or cellular differentiation be different in 
different cell types.
3.1.1 Is the differential expression of the IFN genes the 
result of several alternative pathways?
The existence of several pathways, each of which results in the induction 
of a different set of the IFN genes, could explain the differential expression 
of the IFN genes. As different induction protocols do not significantly affect 
the proportion of IFN mRNA produced by a particular cell line (Hiscott et al., 
1984a), the existence of several pathways seems unlikely.
3.1 .2 The role of messenger stability and translational
efficiency in the differential expression of the IFNs.
Messenger stability and the rate of translation have been implicated in 
influencing the production of active IFN-p following induction (see Section 
1.13). The observation that that IFN-p production does not always correlate 
with mRNA levels indicates that translation may contribute to the differential 
synthesis of the IFNs (Hiscott et al., 1984a).
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Although messenger stability and the efficiency of translation may 
contribute in part to the level of IFN-p synthesis in the cell, there is no 
evidence that similar mechanisms are involved in the differential 
expression of the a-IFNs (see Section 1.10). Consequently, it seems 
unlikely that such mechanisms can be used to explain the differential 
synthesis of the a-IFN genes.
3.1 .3 What role does development play in the differential 
expression of the IFN genes?
The differential expression of the IFN genes may be explained if in 
different cell types the individual IFN genes are more or less susceptible to 
induction as a consequence of developmental control. The effect of 
differentiation on the regulation of the IFN genes has been demonstrated 
by Hiscott et al. (1984b) and Streuli (1986) who, using leukemic leukocytes 
arrested at various stages of hematopoietic differentiation, showed there to 
be remarkable differences in the proportion of the individual IFN mRNAs 
produced (see Section 1.10). Further evidence of the effect of differentiation 
on IFN gene expression comes from studying the differentiation of 
pluripotential embryonic carcinoma (EC) cells. EC cells do not produce IFN 
in response to induction with either virus or poly rl-rC, nor are they sensitive 
to its effects (Burke et al., 1978). However, upon differentiation, the EC cells 
acquire the ability to both produce and respond to IFN (Burke et al., 1978; 
Francis and Lehman, 1989).
Differentiation of cells is accompanied by a variety of epigenetic changes 
which include alterations in the pattern and level of DNA methylation and in 
the overall chromatin structure. Such changes in genome structure are 
known to influence gene expression (for review see Gross and Garrard, 
1988) and may directly or indirectly explain the tissue-specific expression 
patterns of the IFN genes.
a) Methylation of DNA.
Methylation of the genome is widespread in vertebrates where 60-90% 
of CpGs are methylated in a pattern inherited from one generation to
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another in a tissue and species-specific manner (Waalwijk and Flavell, 
1978; Mandel and Chambon, 1979; McGhee and Ginder, 1979). Evidence 
from the study of a large number of individual tissue-specific genes 
revealed a correlation between the expression of these genes with the 
undermethylation of their sequences (Mandel and Chambon, 1979; Shen 
and Maniatis, 1980; Bird et al., 1981; Ott et al., 1982; Grainger et al., 1983). 
Typically these genes are highly methylated in non-expressing cell types 
but are considerably undermethylated (particularly in the CpG sites located 
in the 5'-flanking sequences of these genes) in tissues in which they are 
expressed (Kruczek and Doerfler, 1982; Busslinger et al., 1983; Bird,
1984). Furthermore, Busslinger et al. (1983) showed that in the case of the 
human yglobin gene hypermethylation is sufficient to repress expression. 
In fibroblasts, the endogenous y-globin gene is heavily methylated and 
unexpressed, yet unmethylated copies of this gene are transcriptionally 
active when introduced into the same cell. Genes methylated in vitro and 
introduced in the same transfection assay are inactive, illustrating the role 
that methylation plays in the regulation of some genes.
The availability of cell lines that undergo differentiation in tissue culture 
allowed the direct examination of whether methylation of the genome was 
involved in the developmental regulation of gene expression following 
differentiation. Mouse erythroleukemia cells undergo erythroid differention 
after exposure to chemical inducers, which results in an induction of globin 
mRNA (Gambari et al., 1979) and correlates with a decrease in the level of 
DNA methylation (Christman et al., 1977, 1980).
A more direct correlation between methylation, gene expression and 
differention was demonstrated by Yisraeli et al. (1986) who showed that a 
fully methylated skeletal muscle a-actin gene transfected into fibroblasts is 
inactive, whereas when introduced into myogenic cells it is demethylated 
and expressed. Tissue-specific repression of gene function as a 
consequence of de novo methylation has also been observed. Gautsch 
and Wilson (1983) showed that in undifferentiated EC cells replication of 
Moloney murine leukemia virus (M-MuLV) is blocked as a result of de novo 
methylation of the proviral DNA at sites not methylated in virus replicating in 
differentiated cells. Furthermore, Speers et al., (1980) showed that 
M-MuLV-infected EC cells could be induced to produce virus following 
differentiation.
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Clearly the pattern of methylation of a particular gene can influence its 
expression, and differentiation can influence the degree to which a 
particular gene is methylated. Consequently, methylation could 
conceivably be involved in the differential control of the IFN genes. In 
different cell types there may be tissue-specific regulators of methylation 
with varying affinities for CpGs depending on their flanking sequences and 
hence may display specificity for a particular set of interferon genes and in 
so doing influence the pattern of expression of these genes.
b) Changes in chromatin nuclease hypersensitivity.
Sites of nuclease hypersensitivity present in chromatin are thought to 
correspond to nucleosome free regions that represent an opening up of 
specific tracts of the chromatin to allow access of trans-activating factors to 
important cis-acting DNA sequences (reviewed in Gross and Garrard, 
1988). Nuclease hypersensitive sites are usually located in the promoter 
regions of genes committed to transcriptional activation (Wu, 1980; 
Lowenhaupt et al., 1983; Vitek and Berger, 1984; Azizkhan et al., 1986; 
Bentley and Groudine, 1986; Cartwright and Elgin, 1986; Shimada et al.,
1986). Changes in the chromatin structure following differentiation have 
been studied by investigating the susceptibility of sequences surrounding 
tissue-specific genes to digestion with nuclease and correlating this to 
gene expression. Such an approach revealed that hypersensitive sites 
were associated with tissue-specific expression, appearing in a tissue- 
specific, transcription-dependent manner (Shermoen and Beckendorf, 
1982; Crowder and Merlie, 1986; Renaud and Ruiz-Carrillo, 1986; Ayres et 
al., 1987).
Coverney et al. (1984) studied the changes in the DNasel 
hypersensitivity of the IFN-p gene following differentiation and/or induction 
in EC cells. The appearance of DNasel hypersensitive sites in the IFN-p 
gene correlated with its induction in differentiated cells only; in non­
differentiated EC no changes were detected following induction. 
Differentiation of the EC cell failed to elicit any alterations in chromatin 
structure of the IFN-p gene as judged by DNasel hypersensitivity. A similar 
correlation of increased DNasel sensitivity of this gene following induction 
was reported by Higashi (1985).
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These results appear to correlate the relaxing of the chromatin structure 
of IFN-p locus with induction (ie. to the activation of transcription) rather 
than with changes associated with differentiation. It therefore seems rather 
unlikely that changes in chromatin structure determine which of the IFN 
genes are in a conformation amenable to viral induction.
An alternative mechanism by which differentiation may influence the 
expression of the IFN genes could be based on the expression of trans- 
activating factors that interact directly with the IFN regulatory elements 
either to activate or repress their expression. Evidence in support of such a 
mechanism was provided by Haggarty et al. (1988), who found that the 
pattern of DNA-binding proteins with specificity for the IFN-p promoter 
different between differentiated and non-differentiated EC cells. In gel 
retardation experiments using nuclear extracts prepared from differentiated 
and non-differentiated EC cells a common band was observed interacting 
with the promoter region of the IFN-p gene, while each extract had at least 
one additional distinct band. These extract-specific DNA/protein 
interactions may reflect the binding of tissue-specific factors to the IFN-p 
promoter. Furthermore, it was found that cell fusions between EC and 
differentiated cells (which were normally competent for the IFN gene 
expression) produced hybrids that were unable to produce IFN (like the 
parental EC cells). The ability of these cells to produce IFN was recovered 
following differentiation, indicating that the EC cells contain what appears 
to be a tissue-specific repressor of IFN-p transcription. If an alteration of 
chromatin following differentiation were to influence the expression of such 
tissue-specific regulators of IFN expression in different cell types, then this 
may provide an explanation as to how the differential expression of the IFN 
genes is achieved.
3.1.4 A hybrid iFN-a1/p-g!obin gene but not the endogenous 
IFN-a1 gene is virus inducible in HeLa cells: The 
implications for the mechanisms of differential 
expression of the IFN genes.
The observation that in HeLa cells a hybrid reporter gene under the 
control of two copies of the VREal, but not the endogenous IFN-a1 gene is 
virus inducible (see Section 2.1) has important implications as to which of
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the mechanisms discussed above may be involved in the regulation of 
differential expression of this gene. This finding indicates that VREal 
contains all the sequences necessary to confer virus inducibility upon a 
truncated rabbit p-globin gene in HeLa cells, although when in the context 
of the endogenous gene these sequences are no longer sufficient for 
induction. This is consistent with the endogenous gene being under some 
form of negative control that the plasmid-borne sequences are able to 
evade. Such a situation may occur if either sequences up or downstream of 
VREal are important in the repression of the expression of this gene or if 
the chromatin structure plays a role in determining inducibility. Alternatively 
virus induced-expression of the hybrid reporter may arise if messenger 
stability plays an important role in the level of expression.
The failure of the endogenous IFN-a1 gene to be induced by virus in 
HeLa cells could simply reflect the interaction of negative regulating 
cis-acting DNA sequences with repressor molecules. It is conceivable that 
such elements are present within the IFN-a1 promoter, but outside the 
VREal element. Although no such elements were identified during the 
deletion analysis of the IFN-a1 promoter in L929 cells (Ragg and 
Weissmann, 1983; Ryals et al., 1985) this does not rule out the possibility 
that a tissue-specific negative regulatory element may be active in HeLa 
cells.
The role of messenger stability in regulating the level of IFN-a1 
production in HeLa cells cannot be addressed by the experiment 
performed in Section 2.1. As the expression from the two promoters was 
assayed by measuring the levels of induction of two different transcripts, the 
effects of messenger stability and promoter activity cannot be distinguished; 
therefore such a mechanism is not excluded.
The results of Section 2.1 are also compatible with the repression of the 
IFN-a1 gene being a result of its epigenetic state, since the transiently 
introduced IFN-a1/p-globin gene would be unaffected by changes in 
chromatin structure and/or methylation of the DNA. Consequently the 
introduced gene would be able to avoid any negative regulation that arises 
as a result of epigenetic changes that are imposed upon the endogenous 
gene.
To determine whether any of these mechanisms are involved in the 
control of expression of the IFN-a1 gene in HeLa cells, a number of
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additional experiments would need to be done. By using longer IFN-a1 
promoter fragments connected to the p-globin gene the question of whether 
tissue-specific regulatory elements are present further up or downstream of 
the VREal may be answered. The role of chromatin structure and 
methylation in the tissue-specific regulation of the IFN genes could be 
studied using homologous recombination to substitute the IFN-a1 gene 
with that of the hybrid IFN-a1 /p-globin or a 'tagged' IFN-a1 gene to 
determine whether these sequences when in the same context as the 
endogenous gene are repressed or not. The function that methylation plays 
could be addressed by treating HeLa cells with 5-azacytidine, a potent 
demethylating agent, and determining whether the pattern of expression of 
the IFN-a1 gene alters. Alternatively, hybrid genes could be methylated in 
vitro (Busslinger et al., 1983) prior to introducing them into cells to see if 
they are repressed in cell lines that do not normally express the IFN-a1 
gene and conversely, whether they are demethylated and consequently 
expressed in cell lines that do express IFN-a1.
The human p-like-globin genes are a cluster of five active genes 
comprising of approximately 60 kb of DNA that are expressed in a 
developmental and tissue-specific manner. Although all the sequences 
necessary for the induction of the p-globin gene during erythroid 
differentiation are located immediately 5' inside and 3' of the p-globin gene 
(Charnay et al., 1984; Wright et al., 1984) when introduced into transgenic 
mice this gene is weakly expressed in a position dependent manner 
(Chada et al., 1985; Magram et al., 1985; Kollias et al., 1986). Using 
regions corresponding to erythroid-specific DNasel hypersensitive sites 
(Groudine et al., 1983; Tuan et al., 1985; Forrester et al., 1986) as a guide, 
Grosveld et al. (1987) constructed a 'minilocus' consisting of the p-globin 
gene and sequences originally located approximately 50 kb 5' and 20 kb 3' 
of the p-globin gene. This 38 kb minilocus was expressed in a tissue- 
specific, position independent manner in transgenic mice at a level 
comparable to that of the endogenous mouse p-globin gene and 
proportional to the copy number. Thus it appears that at least for the p- 
globin gene sequences flanking the gene considerable distances away 
can influence its expression.
A similar situation may exist for the IFN-a gene locus. If tissue-specific 
activator or repressor sequences were scattered through out the IFN-a 
gene locus then such sequences might regulate in a tissue and
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developmental manner the expression of the IFN genes. It has been 
illustrated that such sequences can operate over distances of up to 50 kb, 
(Grosveld et al., 1987) conceivably when even further away from the 
transcription start their effect may be less pronounced and the distance a 
gene is from such an active activator and/or repressor sequences may 
determine to what extent it is expressed in a particular cell type.
Although a variety of mechanisms can be postulated to explain the 
repression of the IFN-a1 gene in HeLa cells the possibility that it is the 
result of the inactivation of the endogenous gene due to some deletion or 
rearrangement cannot be ruled out.
3.2 Tetrameric hexanucleotides mediating virus 
inducibility are of distinct types.
Oligonucleotides of the type (GAAANN)4 mediating virus inducibility 
were classified into three types based on their in vivo properties. 
Furthermore, gel retardation analysis indicated that members of each type 
of oligonucleotide bound a similar set of proteins and that type I 
oligonucleotides and VREp shared affinity for some of the same proteins, 
as did the type II oligonucleotide and VREal.
3.2.1 Type I oligonucleotides.
Type I oligonucleotides (GT4, GC4, CT4 and CC4) showed no 
constitutive expression, were induced not only by virus and lFN-y but also 
by cotransfection with an IRF-1 expression plasmid and displayed inducible 
enhancer coupling (Section 2.2). Furthermore, it was demonstrated that 
these oligonucleotides were also induced by IFN-a and when placed 
between the TATA box and a close-by SV40 enhancer, silenced the 
transcriptional activation attributed to the enhancer (MacDonald et al., 
1990 2).
Using 32P-labeled GT4 as a probe in gel retardation competition 
analysis it was shown that type I oligonucleotides were equally efficient
All references to MacDonald et al. (1990) refer to work done by the co-authors.
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competitors of the retarded bands (Section 2.3.1). Subsequently, it was 
demonstrated that all type I oligonucleotides generated the same pattern of 
retarded bands when used as probes and that all bound recombinant IRF-1 
(MacDonald et al., 1990).
These findings support the conclusion (Miyamoto et al., 1988; Fujita et 
al., 1989a; Harada et al., 1989) that IRF-1 is responsible, directly or 
indirectly, for the activation of transcription by type I oligonucleotides. 
Uninduced L929 cells contain low levels of IRF-1 (T. Taniguchi, personal 
communication) but exposure to virus (or IFN-a) causes a strong increase 
in the level of IRF-1 mRNA which precedes the appearance of IFN-p mRNA 
(Miyamoto et al., 1988; Harada et al., 1989). Miyamoto et al. (1988) 
proposed that the increase in level of IRF-1, and perhaps in addition a 
modification of the pre-existing (possibly inactive) IRF-1, activates 
transcription.
De novo synthesis of IRF-1 by itself is likely not the only physiological 
mechanism by which virus induces type I oligonucleotide promoters, 
because full virus inducibility is observed in the presence of cycloheximide, 
under conditions where protein synthesis is >97% inhibited (Hug, 1988; 
Ruffner, 1990). It must therefore be concluded that either pre-existing IRF-1 
is released or activated by virus induction, that there is an alternative 
pathway for inducing type I oligonucleotide promoters in L929 cells, or less 
likely that residual IRF-1 in the presence of cycloheximide suffices for full 
induction.
Assuming that IRF-1 were the sole activator of type I oligonucleotide 
promoters then a latent form would have to exist that following induction 
could be activated without the requirement for protein synthesis. Activation 
of pre-existing IRF-1 may be achieved by dissociation from an inhibitory 
molecule that represses the activating activity of IRF-1. Alternatively some 
post-translational modification that either directly activates the IRF-1, 
increases its DNA binding affinity or alters its location could account for this 
activation in the absence of protein synthesis. Although there are no 
indication as to how such a modification may occur with IRF-1, precedents 
for each of these modes of activation have been described in other 
systems.
NF-k B, the B cell-specific DNA binding protein that recognizes 
cis-regulatory sequences within the enhancer of immunoglobulin genes
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(Sen and Baltimore, 1986a) is thought to be important in regulating the 
tissue-specific developmental expression of the immunoglobulin genes. 
The induction of NF-kB does not require protein synthesis, although no 
NF-kB binding activity is detectable in either cytoplasmic or nuclear extracts 
prepared from pre-B cells (Baeuerle and Baltimore, 1988a). However, 
NF-kB can be activated in pre-B cells following induction with LPS or 
phorbol esters (Sen and Baltimore, 1986b) and in cytosolic extracts from 
uninduced cells treated in vitro with denaturing agents such as 
deoxycholate (Baeuerle and Baltimore, 1988a). In pre- and non-B cells 
NF-kB is associated with a cytoplasmic inhibitor (I-kB) and upon induction 
this complex dissociates to release active NF-kB which is translocated to 
the nucleus whereupon it interacts with its binding sites to stimulate 
transcription of the immunoglobulin genes. (Baeuerle and Baltimore, 
1988a, 1988b, 1989). Recent evidence indicates that a phosphorylation 
event is involved in the activation and translocation of NF-kB from the 
cytoplasm of non-B cells (Shirakawa and Mizel, 1989).
The heat shock genes are induced following exposure to increasing 
temperature (reviewed in Lindquist, 1986). This response is mediated by 
the heat shock transcription factor (HSTF), which binds the cis-regulatory 
heat shock element (HSE) and occurs in the absence of fresh protein 
synthesis (Pelham, 1982; Parker and Topol, 1984; Wu, 1984; Kingston et 
al., 1987; Sorger et al., 1987; Wiederrecht et al., 1987; Wu et al., 1987). 
Regardless of their origin, eukaryotic HSE are nearly invariant and HSTFs 
do not distinguish between the HSE from various species (Sorger et al., 
1987; Wiederrecht et al., 1987). Surprisingly though the HSTFs of yeast 
and higher eukaryotes are regulated differently.
In yeast, levels of HSTF/HSE binding are similar in heat shocked and 
control cells (Sorger et al., 1987). Following heat shock, the yeast HSTF 
has altered electrophoretic mobility, a transition that can be reversed by 
phosphatase treatment (Sorger et al., 1987; Sorger and Pelham, 1988). 
Consequently it appears that yeast HSTF can activate transcription only 
after heat shock-dependent phosphorylation, which may create an acidic 
activation domain analogous to those of GCN4, GAL4 and VP16 (Hope and 
Struhl, 1986; Ma and Ptashne, 1987; Triezenberg et al., 1988).
In contrast to yeast, HSTF binding activity of higher eukaryotes can only 
be demonstrated in cell extracts prepared from heat shocked cells
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(Kingston et al., 1987; Sorger et al., 1987; Zimarino and Wu, 1987). Thus, 
unlike yeast, the DNA binding activity of HSTF in higher eukaryotes 
appears to be regulated by heat shock. Activation of DNA activity must 
involve some form of post-translational modification of pre-existing HSTF 
since it can be detected in extracts from cells heat shocked in the presence 
of cycloheximide (Kingston et al., 1987; Sorger et al., 1987; Zimarino and 
Wu, 1987). The DNA binding activity of HeLa HSTF can be activated in vitro 
by heat shocking extracts prepared from control cells (Larson et al., 1988). 
However, unlike the activation of yeast HSTF this does not appear to 
require protein phosphorylation, since it can occur in the absence of ATP 
(Larson et al., 1988). Although phosphorylation is not required in the 
activation of HeLa HSTF DNA binding activity evidence suggests that the 
activation of its transcriptional activity does require phosphorylation (Larson 
et al., 1988).
Activation of gene expression in response to hormones can also 
proceed in the absence of protein synthesis (reviewed in Yamamoto,
1985). The best understood hormone-mediated activation of gene 
expression is that of the glucocorticoid receptor. The glucocorticoid 
receptor is a cytosolic protein that interacts both with ligand and the genes 
it activates. Upon the binding of hormone the glucocorticoid receptor 
undergoes a conformational transition which results in the translocation of 
the receptor/ligand complex to the nucleus where it binds directly to cis- 
regulating DNA sequences to stimulate transcription from adjacent 
promoters (Picard et al., 1988). Although nuclear localization is not 
sufficient for transcriptional activation by the glucocorticoid receptor it is 
necessary and illustrates how nuclear localization may play an important 
role in the regulation of gene expression by latent activators (Picard et al.,
1988).
The mechanism by which plasmid-directed IRF-1 expression activates 
type I oligonucleotide promoters is not clear. Perhaps, IRF-1 is bound by an 
inhibitor shortly after synthesis, that dissociates following induction. Such a 
mechanism requires a delicate balance of activator and inhibitor in order to 
maintain the balance. Thus, over-expression of IRF-1 from an expression 
plasmid may upset this balance, titrating out the inhibitor and thus leaving 
the excess IRF-1 free to stimulate transcription.
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If activation of IRF-1 were the result of a post-translational modification, 
then stimulation of type I oligonucleotide promoters by cotransfection with 
IRF-1 may occur in a variety of ways. For example, if IRF-1 were 
synthesized in an active form then the excess of newly synthesized factor 
may be able to stimulate transcription before being converted to an inactive 
state. Alternatively, if IRF-1 were produced in an inactive form, then a low 
basal activating capacity may convert sufficient amounts of the over­
expressed factor to the active form to enable activation of the 
oligonucleotide promoters.
If the activation of transcription by IRF-1 were to involve its transfer from a 
cellular compartment where it is unable to interact with the DNA to one 
where it can, then stimulation of transcription by cotransfection with the 
IRF-1 expression plasmid may occur if the excess of newly synthesized IRF- 
1 is able to stimulate transcription prior to it becoming compartmentalized. 
Alternatively, the over-expression of IRF-1 may simply overwhelm the 
storage facilities, resulting in the excess being free to migrate to the 
nucleus or a basal translocation activity may result in the transfer to the 
nucleus of sufficient amounts of the over-expressed IRF-1 to stimulate 
transcription.
In addition to being induced by virus, type I oligonucleotide promoters 
are also induced by both IFN-a and -y (Section 2.2.5 and MacDonald et al., 
1990). Type I IFN leads to a rapid increase in IRF-1 mRNA (and presumably 
protein; Harada et al., 1989), indicating that IFN induction of type I 
oligonucleotides probably occurs as a result of the synthesis of IRF-1.
The SV40 enhancer, when placed closely upstream of a minimal 
promoter, displays a strong distance-dependent stimulation of transcription 
(Pelham, 1982; Hen et al., 1982; Treisman and Maniatis 1985; Kuhl et al.,
1987); this can be overcome when certain upstream elements are placed 
between the TATA box and the enhancer. The ability of upstream 
sequences to mediate the enhancer effect upon a minimal promoter was 
termed enhancer coupling (see Section 2.2.4). Enhancer coupling 
probably reflects the extent to which the SV40 enhancer or associated 
proteins can stabilize the binding of factor(s) to the tetrameric 
hexanucleotides present in the promoters of the test genes. The amount of 
enhancer coupling displayed by a particular element probably reflects its 
affinity for the cognate binding factors, that is, the stronger the affinity of a
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factor for a particular element, the less 'stabilization' is required for maximal 
cooperation between itself and the transcription initiation complex, which 
results in a low coupling index. Conversely, CC4 (induced coupling index 
2.4) following this hypothesis should have stronger affinity for its factor 
(IRF-1 ?) than does GT4 (induced coupling index 16), whether this is the 
case or not has never been determined.
Silencing (Kuhl et al., 1987) which was mediated by all type I 
oligonucleotides, was abolished by viral induction (MacDonald et al., 
1990). Presumably, factors binding to type I oligonucleotides in the 
uninduced state prevent the productive interaction between the enhancer 
and the TATA box, either by steric hindrance or by entering into an 
unproductive association with the transcription initiation complex.
IRF-2, which is related to IRF-1 and has the same binding specificity but 
no activating capacity, may be responsible for this effect. R66 cells which 
lack IRF-like activity neither respond to viral induction nor silence enhancer 
activity (Fujita et al., 1988). Harada et al. (1989) were able to reconstitute 
silencing in R66 cells by cotransfecting a reporter gene under the control of 
(AAGTGA)4 (a permutation of GT4) with an IRF-2 expression plasmid, 
illustrating the potential role that IRF-2 may play in silencing.
IRF-1 and -2 display striking homology in their N-terminal regions, the 
DNA binding domain, while the C-terminal region, which in IRF-1 is 
responsible for transcriptional activation, displays little if any homology 
(Fujita et al., 1989a; Harada et al., 1989). If the region involved in 
cooperation between IRF-1 and the TATA box factors resides in the 
N-terminal portion then it is conceivable that the corresponding domain of 
IRF-2 interacts with the initiation complex forming an unproductive 
association that blocks the effects of the enhancer. A. Keller and T. Maniatis 
(personal communication) characterized an 88 kD polypeptide containing 5 
zinc fingers, PRDI-BF1, which is clearly different from IRF-1 and -2 and 
blocks expression mediated by PRDI; it is therefore another candidate for a 
silencing effector.
The hexanucleotides which were examined as tetramers do not on their 
own constitute recognition sequence subunits, as shown by the finding that 
they do not confer inducibility on a minimal promoter even when assayed in 
conjunction with an enhancer (D. Naf and S. Hardin; unpublished results). 
They are therefore not analogous to the enhansons of the SV40 enhancer
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(Ondek et al., 1988; Kanno et al., 1989), but rather the result of the 
fortuitous generation of sequences resembling natural IRF binding sites, 
when tandemly repeated. Harada et al. (1989) have suggested that the 
sequence recognized within (AAGTGA)4 is AA(G/A)TG(A/G)AA while Keller 
and Maniatis (1988) proposed AAGTGAAAGT. D. Naf and S. Hardin 
(unpublished results) have found that a dimer of GAAAGT, but not a dimer 
of AAGTGA, mediates virus inducibility, and deduced from this and other 
findings that the active sequence in GT4 is (T)GAAAGTGAAAG(T).
3.2 .2 Type II oligonucleotides.
The only representative, TG4, shows no constitutive activity, mediates 
induction by virus infection, but is stimulated neither by IRF-1 nor IFN and 
does not show silencing (Section 2.2; MacDonald et al., 1990). In contrast 
to type I and type III oligonucleotides, TG4 mediates significant virus 
inducibility only when it is associated with an enhancer which is reflected in 
the inordinately high enhancer coupling index of >70 (Section 2.2). 
However, the 8 fold repeat of GAAATG, TG8, is strongly virus inducible even 
in the absence of an enhancer (Ruffner, 1990). Although TG4 is inducible 
by virus, cotransfection with the IRF-1 expression plasmid fails to activate it, 
indicating that a pathway involving a factor(s) other than IRF-1 is regulating 
the virus induced expression of this sequence.
TG4 exhibits a distinctive gel retardation band pattern of 3 bands 
(MacDonald et al., 1990). One of the TG4-retarded bands (with intermediate 
mobility) was competed by all NN4 oligonucleotides and was thus 
considered to be unspecific (MacDonald et al., 1990). The remaining two 
bands were efficiently competed by both TG4 and VREal but none of the 
other oligonucleotides, and were thus considered potential candidates for 
the factor mediating the virus induction of the type II oligonucleotide and 
VREal (MacDonald et al., 1990).
A striking similarity exists between the octamer sequence ATGCAAAT 
(Falkner and Zachau, 1984; Parslow et al., 1984; Schreiber et al. (in 
press)), TG4 and to a lesser degree with a sequence in VREal designated 
TG sequence':
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(GAAATG)4 g a a a t g g a a a t g g a a a t g g a a a t g
octa sequence ATGCAAAT ATGCAAAT
TG sequence’ GAAATGGAAA
A comparison of the gel retardation patterns given with uninduced 
Namalwa extract by TG4 and the ’hepta-octamer' sequence 
GTG CTC ATG A AT AT G C A A AT C A ATT G G (from the immunoglobulin heavy 
chain promoter; Ballard and Bothwell,1986) was made to determine 
whether the sequence similarity between these two elements had any 
significance. Both oligonucleotides gave the upper of the TG4-retarded 
bands, while only TG4 showed the two lower bands (MacDonald et al., 
1990). Competition of labeled TG4 with the hepta-octa sequence abolished 
the upper but not the lower bands, indicating that the upper band results 
from the interaction of an octamer factor with the octamer-like sequence 
(MacDonald et al., 1990). The hepta-octa sequence interacts with two 
molecules of the ubiquitous OTF-1 or the lymphoid-specific OTF-2 (as 
homo- or heterodimers; Poellinger and Roeder, 1989). As TG4 gave an 
octa-factor-like band shift with L929 cell extract (a fibroblastic cell line) it 
suggests that it is interacting with the ubiquitous octamer factor, OTF-1 
rather than lymphoid-specific, OTF-2.
The observation that OTF-1 bound TG4 raised the question as to whether 
this interaction mediates the virus inducibility of this oligonucleotide. To 
address this question, a dimer of hepta-octa in conjunction with the SV40 
enhancer was tested for virus inducibility. Though this sequence did 
mediate low constitutive activity, induction by virus increased the 
expression only about twofold (Ruffner, 1990) whereas under similar 
conditions TG4 was induced >70 fold. Thus, it seems unlikely that OTF-1 is 
mediating the virus inducibility of this oligonucleotide through its interaction 
with TG4.
The third of the TG retarded bands (the fastest migrating) was specifically 
competed by TG4 and VREal, but by none of the other oligonucleotides 
tested (MacDonald et al., 1990). The protein giving rise to this band was 
designated ’TG protein' and was subject to further analysis. Methylation 
interference experiments indicated that TG protein forms similar contacts 
with a 10-nucleotide sequence common to both TG4 and V R E a l,
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GAAATGGAAA (TG sequence’; see above). Consequently, TG protein is 
considered to be a potential candidate for a factor mediating the virus 
inducibility of both TG4 and VREal by a pathway other than that by IRF-1.
3.2 .3 Type III oligonucleotides.
The type III oligonucleotide CG4 mediates induction by virus but 
responds neither to IRF-1 nor to IFN and does not silence. The 
characteristic features of CG4 are its strong constitutive activity and 
distinctive gel retardation pattern, both of which were attributed to its 
capacity to interact with the ubiquitous transcription factor IEFga (LaMarco 
and McKnight, 1989; MacDonald et al., 1990). IEFga binds to the ’GA’ 
sequence in the immediate early ICP4 promoter of Herpes Simplex virus I 
and is believed to mediate the trans-activating effect of VP16 (Post et al., 
1981; Campbell et al., 1984; Triezenberg et al., 1988). LaMarco and 
McKnight (1989) pointed out that CG4 contains a sequence which 
resembles ’GA’ sequence at 15 out of 17 positions:
'GA' sequence GCGGAACGGAAGCGGAAAC
(GAAACG)4 GAAACGGAAACGGAAACGGAAACG
LaMarco and McKnight (1989) found that IEFga gives a strong footprint 
on CG4 and it was determined that IEFga gave the same strong band 
retardation pattern with both CG4 and the 'GA' oligonucleotide, similar to 
that found with Namalwa nuclear extract (MacDonald et al., 1990). Type I 
oligonucleotides did not bind IEFga, while GG4 showed weak and TG4 
barely detectable binding (MacDonald et al., 1990).
This suggested that IEFga was responsible for constitutive expression 
mediated by CG4 and raised the question as to whether it could also 
mediate virus induction, perhaps as a consequence of being trans­
activated by VP16. Both the 'GA' sequence and CG4 promoted the same 
constitutive transcript levels, but whereas CG4 was 7 fold induced by virus, 
there was no significant stimulation in the case of the 'GA' sequence (data
88
not shown). Furthermore, cotransfection with a VP16 expression plasmid 
(pMSVP16; gift of K. LaMarco) failed to activate transcription of either the 
'GA' sequence or CG4-containing promoters (whether VP16 was expressed 
was not determined) data not shown)). Thus it was concluded that whereas 
constitutive activity of CG4 may well be mediated by IEFga, virus inducibility 
depends on some other or on additional proteins. Furthermore, the 
inducibility of CG4 appears not to be the result of VP16 trans-activation of 
CG4 via protein/protein interactions with IEFga.
With the the exception of its constitutive activity, CG4 shares properties 
with that of the Type II oligonucleotide, TG4. Thus, while the constitutive 
activity of CG4 may be mediated by IEFga, its virus inducibility may be 
mediated by TG protein. The sequence similarity between CG4 and TG4 
oligonucleotides is such that if TG protein were to bind to CG4 it could do so 
by making contacts similar to those shown to be important for TG protein 
binding to TG4 (see Figure 15).
The oligonucleotide GG4 gives the same gel retardation band pattern as 
CG4, however with a much lower intensity (MacDonald et al., 1990). It 
shows moderate constitutive activity in some experiments and is stimulated 
by cotransfection with IRF-1, for which it also shows weak binding activity. It 
thus has properties of both type I and type III oligonucleotides.
3.3 The relationship of the NN4 oligonucleotides to the 
IFN-a1 and IFN-p promoters.
3.3.1 The IFN-p promoter.
Maniatis and coworkers identified a 40 bp sequence (VREp; -79 to -39) 
of the IFN-p promoter as being essential for the maximal induction of this 
gene in C127 cells (Goodbourn et al., 1985). Subsequently, by examining 
the effect of a large number of single point mutations, VREp was found to 
consist of two functionally distinct positive regulatory domains (PRDI and 
PRDII) and one negative regulating element ((NRDI) Goodbourn and 
Maniatis, 1988).
PRDI (-79 to -66), contains the sequence AGAAGTGAAAG which differs 
by two (underlined) nucleotides from GAAAGTGAAAG, the sequence 
identified by D. Naf and S. Hardin (unpublished results) as being the
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minimal sequence essential for the virus induction of multimers of GAAAGT 
and AAGTGA. In L929 cells a second PRDI-like sequence (-91 to -80), 
AAAACTGAAAG, is required for optimal inducibility (Fujita et al., 1985, 
1987; Dinter and Hauser, 1987). This sequence differs by two nucleotides 
(underlined) from the minimal virus inducible sequence (see above) and by 
two nucleotides (bold) from the sequence GAAACTGAAA repeated three 
times in the type l oligonucleotide CT4.
Keller and Maniatis (1988) identified two factors that bind PRDI, one in 
uninduced (PRDl-BFc) the other in induced cells (PRDI-BFi), which display 
the same binding specificity, but result in the formation of complexes with 
different electrophoretic mobility. Although the relationship between the 
PRDI binding factors of Keller and Maniatis and IRF-1 and -2 is not clear, it 
seems reasonable to assume that the positive effects of PRDI are mediated 
at least in part by IRF-1. PRDI is itself both virus and IRF-1 inducible (D. Naf, 
unpublished results) and has been shown to bind IRF-1 in vitro (Harada et 
al 1989). Consequently it would appear that the virus and IFN inducibility of 
the type I oligonucleotides is due to the fortuitous generation of PRDI-like 
sequences created as a result of the multimerization of the hexamers, 
which like PRDI are probability activated by IRF-1.
Keller and Maniatis (1988) identified a factor, PRDII-BF, that binds to the 
PRDII sequence (-68 to -57). Clark and Hay (1989) and Hiscott et al. (1989) 
pointed out the resemblances between PRDII (GGGAAATTCC), the EBP1 
binding site in the SV40 enhancer (GGAAAGTCCC), the NF-k B binding 
site in the k light chain enhancer (CGGAAAGJCC) and the H2TF1 binding 
site in the mouse class I histocompatibility gene enhancer 
(GGGGATICCC). Lenardo et al. (1989) and Visvanathan and Goodbourn 
(1989) argue convincingly that PRDII-BF is indistinguishable from NF-k B. 
This factor is constitutively active in B cells and is released from an inactive 
complex (Baeuerle and Baltimore, 1988b) by LPS or TPA in pre-B cells 
(Sen and Baltimore, 1986a) or with TPA in non-B cells (Sen and Baltimore, 
1986a, 1986b). Moreover, NF-k B can also be activated by double-stranded 
RNA (Lenardo et al., 1989; Visvanathan and Goodbourn, 1989), virus 
infection (Fujita et al., 1989b) TNF-a and 1L-1 (Osborn et al., 1989). In line 
with these findings, dimeric PRDII mediates constitutive activity in B cells 
(Lenardo et al., 1989) and virus inducibility in non-B cells such as L929 
cells (Fan and Maniatis, 1989). However, some L929 sublines contain
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constitutively active NF-kB and in such cell, when tandemly repeated, 
PRDII is constitutively active (Fujita et al., 1989b).
Thus, the induction of the IFN-p promoter is envisaged as coming about 
by (a) the activation (and/or de novo synthesis) of IRF-1 or an IRF-1-like 
factor (for potential mechanisms see Section 3.2.1) and (b) release of 
NF-kB as a consequence of exposure to virus or double-stranded RNA. 
This results in the simultaneous binding of one or two 'activated' factor 
molecule(s) to the IRF binding sites (one of which is PRDI, the other 'PRDI- 
like' site is located between -91 to -80) and of an NF-kB molecule to PRDII; 
the requirement for cooperative binding has been proposed by Fan and 
Maniatis (1989), and Fujita et al. (1989b). The binding of only one of these 
factors is insufficient to activate transcription as judged by the fact that IRF-1 
expression alone gives only 2.7 fold stimulation of VREp, and that the IFN-p 
promoter is not active in NF-KB-containing B cells. In support of the 
hypothesis that expression of the IFN-p gene requires the simultaneous 
binding of two of more molecules of NF-kB and/or IRF-1 is the observation 
that single copies of PRDI or PRDII alone are insufficient to mediate virus 
induction while multimers of either PRDI or PRDII can. Presumably once 
multimerized these elements bind at least two molecules of either NF-kB or 
IRF-1 and in so doing can function as virus-inducible regulatory elements 
(Fujita et al., 1989b; Fan and Maniatis, 1989).
When used in conjunction with an SV40 enhancer at a distance, a single 
copy of PRDI can confer both virus and IRF-1 inducibility upon a minimal 
promoter (D. Naf, unpublished result). This finding indicates that the 
binding of a single IRF-1 molecule is sufficient to activate transcription 
when supported by an enhancer. Whether this effect is the consequence of 
enhancer coupling 'stabilizing' the IRF-1/PRDI interaction or of the 
enhancer supplementing some function normally supplied by the binding of 
a second molecule is not known. Even when supported by an enhancer, 
VREp, which contains a single PRDI element, is only stimulated 2.7 fold 
comparing to the 31 fold inducibility of PRDI. This indicates that activation of 
VREp, in addition to requiring the simultaneous binding of two molecules 
may also require the disengagement of putative repressors from PRDI 
and/or NRDI, an event also elicited by induction.
In addition to being inducible to virus, multimers of a PRDI-like sequence 
((AAGTGA)2), (but not PRDII) are inducible by IFN (Fan and Maniatis,
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1989). Although VREp contains a single PRDI domain, it is not inducible by 
IFN (M. Chaturvedi, unpublished result). The inability of IFN to activate 
VREp although it can induce the expression of IRF-1 (Harada et al., 1989), 
may be due to its inability to elicit the release of active NF-kB and/or relieve 
VREp of its negative repression. Alternatively, it may be that simultaneous 
binding of two molecules of IRF-1 is required for activation by IRF-1 and 
thus a second PRDI site required, such as the PRDI-like sequence present 
in VREP' but absent from VREp (Figure 17).
The role of IRF-2 in the induction of the IFN-p gene is not clear. It has 
been suggested that it may serve as repressor (T. Taniguchi personal 
communication to C. Weissmann) or placeholder for IRF-1 in chromatin 
(Harada et al., 1989). Presumably, IRF-2 would keep the chromatin in an 
open configuration that would be amenable to the rapid binding of IRF-1 
following induction, leading to expression of this gene
The contribution of repression and cooperative binding of IRF-1 and 
NF-kB to the regulation of VREp could be assessed by comparing the 
transcriptional properties of VREp and PRDI-PRDII in B and non-B cells 
under different induction conditions. If the binding of a single molecule of 
either IRF-1 or NF-kB were sufficient to activate transcription and no 
repression were operative, then both constructs would be constitutively 
expressed in B cells (which contain active NF-kB) but would require either 
cotransfection with an IRF-1 expression or TPA induction (to release active 
NF-kB) to be active in non-B cells. If on the other hand, a repressor were 
operative, then the PRDI-PRDII construct would be active as described 
above, while the VREp promoter (which contains the NRDI element; 
Goodbourn and Maniatis, 1988) would remain repressed under all the 
above conditions.
If simultaneous binding of IRF-1 and NF-kB were required for activation 
then both constructs would be constitutive when cotransfected with an 
IRF-1 expression plasmid in B cells and TPA inducible in non-B cells. If 
repression were involved, the VREp construct but not the PRDI-PRDII 
element would be inactive under these conditions.
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3.3.2 The IFN-oc1 promoter.
A 46-bp region within the 5’ flanking sequences of the human IFN-a1 
gene (VREal; -109 to -64) was identified as being sufficient to mediate full 
induction by virus in L929 cells (Ryals et al., 1985). VREal, while mediating 
induction by virus, shows no constitutive activity and is neither stimulated 
by cotransfection with an IRF-1 expression plasmid nor by IFN, and does 
not silence.
The IFN-a1 promoter contains two sequences reminiscent of PRDI sites. 
One, GAAAGAAAAAC, is within VREal between positions -97 and -8 6 , 
while the other GAAAGTGGAAATC (-56 to-45) lies between VREal and the 
TATA box (’PRDI-like sequences' in Figure 17). Despite the presence of an 
PRD1-like sequence, the binding of IRF-1 to VREal is much weaker than to 
VREp, which is in turn weaker than to (AAGTGA)4 or (GAAAGT)4 (Harada 
et al., 1989; MacDonald et al., 1990). Furthermore, unlike PRDI, (believed 
to be the physiological target IRF) neither of the IFN-a1 PRDI-like binding 
sites mediate virus inducibility when assayed in conjunction with the SV40 
enhancer at a distance (D. Naf, unpublished result). Taken together with 
the observation that an IRF-1 expression plasmid fails to activate V R E al, 
these findings imply that the virus inducibility of VREal and therefore 
presumably of the IFN-a1 gene occurs by a pathway other than that 
involving IRF-1.
Although the 5' portion of VREal does not appear to be involved in the 
IRF-1 activation, 5 'truncation analysis (Ragg et al., 1983; Ryals et al., 1985) 
as well as the fact that an A->C conversion in GAAAGCAAAAAC of VREal 
greatly reduces its virus inducibility (MacDonald et al., 1990) show that this 
region contributes significantly to the virus response of VREal. Kuhl et al. 
(1987) showed that a tetramer of a 20 bp subsequence of V R E a l, 
tetra-repA (which contained a small deletion causing the two central units 
to overlap by one nucleotide), efficiently mediated virus inducibility. 
Consequently it would appear that either repA (-101 to -82; see Figure 17) 
or a sequence generated as a result of its multimerization may be 
contributing to the virus inducibility of VREal. This element may be 
functionally equivalent to PRDI of VREp, as in addition to being inducible to 
virus, tetra-repA was also shown to silence (Kuhl et al., 1987), a 
characteristic of PRDI (and PRDI-like elements). To date nothing is known 
about factors interacting with repA, though it appears that neither IRF-1 nor
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-2  interact with this sequence as judged by methylation interference 
experiments (Harada et al., 1989).
VREal, in contrast to VREp, does not bind NF-kB (MacDonald et al., 
1990), in agreement with the statement of Lenardo et al. (1989) that no 
NF-kB activation is operative in induction of the IFN-a1 promoter. Hiscott et 
al. (1989), in gel retardation experiments with nuclear extracts from U937 
cells, have noted that the complexes formed with a fragment slightly shorter 
than VREa are not competed by VREp and vice-versa. Thus, neither IRF-1 
nor NF-kB, the two factors implicated as being responsible for the virus 
induction of the IFN-p gene appear to play a role in the virus induction of 
the IFN-a1 gene.
Gel retardation competition analysis revealed that none of the tetrameric 
hexanucleotides, with the exception of TG4, competed the VREal-retarded 
bands (Figures 13 and 14). Furthermore, VREal, but not VREp is a strong 
competitor of the proteins binding TG4, namely TG protein and OTF-1 
(MacDonald et al., 1990). A perfect match of 10 nucleotides 
(GAAATGGAAA) exists between a sequence in TG4 and one in VREal
(designated TG sequence; see Figure 17). This sequence has been
postulated to be a virus inducible element, contributing to the virus 
inducibility of both the VREal and the type II oligonucleotide, TG4.
In support of the functional importance of the TG sequence are the
findings that a single A->C substitution (GAAATGGAAA) in the TG
sequence of VREal reduces inducibility more than 7-fold (MacDonald et al,
1990) and that the VREal-derived oligonucleotide AGAAATGGAAAGTG 
(which contains the TG sequence, underlined) mediates inducibility by 
virus (D.Naf, unpublished results). Surprisingly the A->C change in the TG 
sequence of VREal, which reduces its inducibility, does not diminish the 
binding of the TG protein (D. Maguire,unpublished results). Such a finding 
might indicate that a protein other than the TG protein is conferring the virus 
inducibility to VREal or that the DNA sequence required for binding and 
activation by TG protein are not the same.
Both TG protein and OTF-1 can bind to VREal as with TG4 and 
consequently they were candidates for mediating the virus inducibility of 
these oligonucleotides (MacDonald et al, 1990; D. Maguire, unpublished 
result). It seems unlikely that octa factors are involved in the viral induction 
of VREal because an authentic dimeric hepta-octa sequence is not virus
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inducible in our system. The TG protein and its binding is strongly impaired 
by methylation of the same GG doublet in the TG sequence of both VREal 
and TG4 (ie. GAAATGGAAA). In agreement with this result is that 
conversion of the TGG sequence (GAAATGGAAA) to CCC in VREal 
virtually abolished the binding of TG protein (D. Maguire,unpublished 
results) Curiously, Harada et al. (1989) showed that methylation of the GG 
doublet within the TG sequence of VREal impaired the weak binding of 
IRF-1 to VREal. Nevertheless, whether or not the TG protein plays a role in 
the virus induction still remains to be established though it interacts with the 
TG sequences of both TG4 and VREal.
The VRE of the murine IFN-a4 promoter which has similar boundaries to 
its human IFN-a1 counterpart, also contains a region resembling RepA 
(TAAAGAAAGTGAAAAGACAA: differences underlined) which contains a 
PRDI-like element (bold), and a sequence very similar to the TG sequence 
(GAATTGGAAA; Raj et al., 1989). Thus, like the human IFN-a1 gene, virus 
induction of the murine IFN-a4 gene may be mediated by a TG-like 
sequence and some as yet unidentified factor interacting with sequences 
contained within the RepA-like domain.
Surprisingly, the natural IFN-a1 promoter, extending either from -675 or 
from -141 to -6 is considerably less active than the VREal segment joined 
to a minimal p-globin promoter in both Namalwa (Figure 16) and L929 cells 
(Naf, 1989). Moreover the VREal dimer is more than 20 times more active 
than the natural IFN-a1 promoter segment. This suggests that even the 
largest IFN-a1 promoter segment tested may lack an enhancer, or contain 
inhibitory sequences.
3.4 Conclusions.
At least two different elements in the IFN-p promoter respond to virus 
induction, namely PRDI and PRDII, which interact with IRF-1 and NF-kB, 
respectively. A novel virus-responsive element in the IFN-a1 promoter, the 
TG sequence which is different from both PRDI and PRDII and interacts with 
a protein distinct from IRF-1 and NF-kB has been identified. Thus, there are 
at least three separate terminal pathways for virus-induced signal 
transmission and the promoters of the IFN-a1 and IFN-p genes, despite 
their apparent homology, contain different response elements. The
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functional differences between the promoters could explain, at least in part, 
the tissue specific expression patterns of the two IFN subfamilies.
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4. EXPERIMENTAL PROCEDURES.
4.1 Plasmid constructs.
Constructs were carried out by standard procedures (Maniatis et al., 1982). Plasmids 
containing tetrameric GAAANN, the 24 bp pBR spacer (pBR322, positions 968-991; 
Sutcliffe, 1978) and the VRE elements (Kuhl et al., 1987; MacDonald et al., 1990; and this 
work) were constructed as follows; all test sequences were synthesized chemically and were 
flanked by a 5'-CIal-compatable overhang (CGAT) on the top and 5'-Hindlll-compatable 
overhang (TTCGA) on the bottom strand (see below). The test sequences were inserted 
between the Clal and Hindlll sites of 42P (no enhancer; Kuhl et al., 1987). For constructs 
with the enhancer at a distance, the test sequences were inserted between the Clal and 
Hindlll sites of a plasmid derived from 39P by replacing the Xhol-Clal fragment (see legend, 
Figure 7) with the 1291 bp Xhol-Scal rabbit p-globin fragment (Clal-linkered at the Seal end) 
(see Table 1, fragment XXVI, in Kuhl et al., 1987). All constructs were verified by 
sequencing.
Tetrameric hexanucleotides;
5 1-cgat GAAANN GAAANN GAAANN GAAANN a-31 
ta CTTTNN CTTTNN CTTTNN CTTTNN ttcga
VREal;
5 1 -cgatGAGTGCATGAAGGAAAGCAAAAACAGAAATGGAAAGTGGCCCAGAa-3' 
taCTCACGTACTTCCTTTCGTTTTTGTCTTTACCTTTCACCGGGTCTttcga
VREp;
5 1 -cgatGAGAAGTGAAAGTGGGAAATTCCTCTGAATAGAGAGAGGACa-31 
taCTCTTCACTTTCACCCTTTAAGGAGACTTATCTCTCTCCTGttcga
RPGa-141/-6 was constructed by inserting the 73 bp Clal/Bspl fragment of CF-2 (IFN-a1 
-141 to -70; Clal-linkered at position -141) and the 64 bp Bstl/Stul fragment of JM12-13 
(IFN-a1 -70 to -6) into Clal/Pvull digested ID1. Plasmids CF-2 and JM12-13 were constructed 
by C. Filippini and H. Ragg respectively.
Plasmids ID1 and 12P (HP6A-109) are from Ryals et al. (1985), 13P and 61P from Kuhl et 
al. (1987), CF1/42P and CF2/42P from C. Filippini (unpublished result) and pIG from Weidle 
and Weissmann (1983). The internal reference plasmids pSTC407-556 and 30P are from 
Severne et al. (1988) and Kuhl et al. (1987) respectively, the IRF-1 expression plasmid, 
pIRF-L from Miyamoto et al. (1988) and the expression vector, CDM8 from Seed, (1987).
4 .2  Purification of oligonucleotides.
Oligonucleotides, synthesized on an Applied Biosystems DNA synthesizer (Model 
380A) were deblocked by incubation with an equal volume (vol) of conc. NH4OH (25%) at
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55 °C for 8 hr. After lyophlizing, the oligonucleotides were dissolved in 150 pi formamide 
loading dye (90% formamide (v/v), 1 mM EDTA, 0.05% bromophenol blue, 0.05% xylene 
cyanol), heated 2 min at 90 °C, chilled on ice and loaded on to a pre-run (1-2 hr) 40x28x0.2 
cm, 12% polyacrylamide (20:1 cross-link), 7 M urea, 89 mM TBE (89 mM Tris-base, 89 mM 
boric acid, 1 mM EDTA) gel. Gels were run 600-700 volts until the bromophenol blue had 
migrated -3 0  cm (length of run depended on the size of the oligonucleotide being purified). 
The gel was sandwiched between two sheets of Saran Wrap placed on a thin layer 
chromatography 60 F254 plate (Merck), DNA visualized by illuminating the gel from above 
with a 254 nm UV lamp and the slowest migrating band excised. The excised gel fragments 
were placed in 10 ml Greiner tubes, crushed with a glass rod and the DNA eluted overnight 
while agitating with 4 ml of H2O at room temperature. The supernatant was passed through a 
glass wool plug prior to being lyophilized, the resulting pellet was resuspended in 400 pi of 
TNE (50 mM Tris-HCI (pH 7.5), 100 mM NaCI, 5 mM EDTA) and fractionated over a 10 ml 
Sephadex G-25/H2O column eluted with H2O. The DNA was localized by measuring the 
absorbance at 260 nm (1 in 30 dilutions), DNA containing fractions pooled, lyophilized and 
the resulting pellets were dissolved in 100 pi of H2O. The concentration of the purified 
oligonucleotides was determined by UV absorbance (260 nm).
4 .3  Large scale plasmid DNA preparation.
250 ml of N-medium (10 mg/ml Bacto-tryptone, 1 mg/ml yeast extract, 1 mg/ml glucose, 
8 mg/ml NaCI, 0.3 mg/ml CaCl2, 10 mM MgS04 ) plus antibiotic (100 pg/ml ampicillin and/or 
10 pg/ml tetracyclin) was inoculated with 0.75 ml of an overnight culture and incubated 
37 °C, 250 rpm until the OD650 was between 0.9 and 1.2 (-6-9 hr). The cells were collected 
at 4500 rpm, room temperature for 15 min (Sorvall GSA rotor), the cell pellet resuspended in 
250 ml of prewarmed (37 °C) N-medium (+ antibiotic) which contained 80 pg/ml of 
chloramphenicol (freshly prepared) and incubated overnight (-12-16 hr), 37 °C, 250 rpm. 
The cells were harvested at 6000 rpm, 4 °C, for 20 min (Sorvall GSA rotor) and resuspended 
in 12 ml of 50 mM Tris-HCI (pH 8). 3 ml lysozyme (10 mg/ml in 50 mM Tris-HCI (pH 8); freshly 
prepared)), 1.8 ml 0.5 M EDTA and 0.75 ml 2% Triton X-100 added with 10 min incubations 
on ice between the addition of each. The cells were then incubated on ice for 45-60 min 
prior to being centrifuged for 30 min at 15000 rpm, 4 °C  (Sorvall SS34 rotor). The 
supernatant was adjusted to a pH of -12.5 by the addition of 1.8 ml of 1N NaOH (freshly 
prepared) while stirring, and was stirred for an additional 10 min at room temperature. The pH 
was subsequently lowered to ~8.3-8.5 by the addition of 8 ml of 1 M Tris-HCI (pH 7.5) and 
stirred for 3 min before the addition of 3 ml of 5 M NaCI and 1 vol phenol (saturated with 0.5 M 
NaCI; unless otherwise stated all phenol, phenol/chloroform and chloroform extractions 
were done using one volume and with phenol equlibrated against TNE ). The aqueous 
phase was extracted twice with chloroform then incubated for 30-60 min with 60 pi of
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RNaseA (10 mg/ml in TNE; preincubated at 85 °C for 10 min) at 37 °C. After precipitation in 
0.65 M NaCI and 6.5% PEG 6000 for 90 min at -10 °C or overnight on ice the DNA was 
collected by centrifugation for 20 min, 9000 rpm, 4 °C (Sorvall HB4 rotor) and resuspended 
in 400 pi TNE. Incubation for 30 min at 37 °C with 20 pi pronase (20 mg/ml; preincubated for 
2 hr at 37 °C) in 1% SDS followed, and then the solution was extracted 3 times with 0.75 vol 
phenol and 0.25 vol chloroform and precipitated with 2 vol ethanol for 30 min at -80°C. After 
centrifugation the DNA pellet was resuspended in 400 pi TE and loaded on to 12 or 36 ml 
sucrose gradients (0.1-0.5 mg and 0.5-1 mg of DNA per gradient respectively) with six 
different density layers (5%, 8 .6%, 12.2%, 15.8%, 19.4% and 23% in 50 mM Tris-HCI (pH 8) 
and 1 mM EDTA) which were centrifuged for 15 hr at 20000 rpm, 15 °C in Beckman SW41 or 
SW27 rotors. The gradients were fractionated, DNA containing fractions pooled, adjusted to 
1x TNE and precipitated with 2.5 vol EtOH -20 °C overnight. The DNA was subsequently 
dissolved in 200-400 pi TE and the yield determined by UV spectroscopy. DNA prepared in 
such a way was used for all purposes without further purification.
4 .4  Isolation of plasmid DNA from mini-preps.
3 ml of N-medium plus antibiotic (100 pg/ml ampicillin and/or 10 pg/ml tetracyclin) was 
inoculated with a bacterial colony and shaken 20-24 hr, 250 rpm at 37 °C. The bacterial pellet 
from 1.5 ml of culture was redissolved in 100 pi of TELT buffer (50 mM Tris-HCI (pH 7.5),
62.5 mM EDTA, 0.4% Triton X-100, 2.5 M LiCI). After the addition of 10 pi lysozyme 
(10 mg/ml; freshly prepared) the suspension was incubated in a boiling water bath for 1 min 
and cooled on ice 5 min. The precipitate was removed by spinning in an Eppendorf 
centrifuge for 8 min at room temperature. The DNA in the supernatant was precipitated with
2.5 vol of ethanol (EtOH) and resuspended in 30-50 pi TE (10 mM Tris-HCI (pH 8), 0.5 mM 
EDTA). The DNA was used directly for restriction analysis but prior to DNA sequencing 
contaminating RNA was removed either by running over a low gelling temperature agarose 
gel or by PEG precipitation.
DNA was incubated in agarose gel loading buffer which contained 50 pg/ml RNaseA for 
5 min before being applied to a 0.8% TAE (Maniatis et al., 1982), low gelling temperature 
agarose (FMC) gel and purified by electrophoresis. The band corresponding to the 
supercoiled plasmid was excised and incubated at 65 °C for 15 min during which time the 
agarose concentration was adjusted to 0.5% with 20 mM Tris-HCI (pH 7.5) and sodium 
acetate (pH 6) added to a final concentration of 0.3 M. The sample was incubated at 37 °C, 
extracted three times with phenol and once with chloroform. The aqueous phase was EtOH 
precipitated with 2.5 vol and the pellet dissolved in 10 pi TE. The yield was estimated by 
running 1 pi in parallel with known amounts of DNA standards on a 1% agarose gel.
PEG precipitations were performed by resuspending the pellet in 200 pi TE to which was 
added 1 pi RNaseA (10 mg/ml in TNE; preincubated at 85 °C for 10 min), incubating 30 min
1 0 0
37 °C, after which 40 pi 5 M NaCI and 67 pi 30% PEG 6000 were added, the mixture was 
vortexed and the DNA precipitated at 90 min -10 °C or overnight on ice. The resulting pellets 
were washed with 80% EtOH, air dried, resuspended in 10 pi TE and used directly for DNA 
sequencing.
4.5 Sequencing of plasmid DNA.
1 pg of DNA in 8 pi TE was denatured with 2 pi of 5x denaturing buffer (1M NaOH,
1 mM EDTA) for 5 min at room temperature. The mix was neutralized by the addition of 1 pi of 
10 x neutralization buffer (2M NH4OAC pH 4.5) and precipitated with 2.5 vol EtOH. The 
precipitate was collected by centrifugation, washed with 80% EtOH and air dried.
Hybridization and primer elongation reactions were performed simultaneously for 5 min at 
room temperature in 33 mM Tris-HCI (pH 7.5), 33 mM NaCI, 13 mM MgCl2, 6.5 mM DTT, 
0.1 mM EDTA, 0.2pM of each of the dNTPs, containing 1.75 pmol sequencing primer (see 
below), 5 pmol a-35S-dATP (600 Ci/mmol; Amersham) and 3.2 units Sequenase enzyme (a 
modified form of T7 polymerase; United States Biochemical Corporation) in a final volume of
15.3 pi. 3.5 pi of the reaction mix were transferred to one of 4 tubes containing 2.2 pi of 
either ddATP-, ddTTP-, ddCTP- and ddGTP-tremination mix (80 pM each of the 4 NTPs, 
8 pM of the corresponding ddNTP, 50 mM NaCI) and incubated at 37 °C for between 5 and 
20 min. Reactions were stopped by the addition of 4 pi formamide loading dye.
After denaturing the samples at 80 °C for 2 min, the fragments were resolved on a 
40x28x0.03 cm, 5.5% polyacrylamide (20:1 cross-link), 7.7 M urea, 89 mM TBE gel using a 
gradient in buffer concentration (89 mM TBE in the upper reservoir, 445 mM TBE in the 
lower reservoir). Gels were run until the bromophenol blue had reached the bottom, 
transferred to Whatman 3MM paper and dried for 30 min at 80 °C under vacuum.
The 'new globin sequencing primer' which annealed to positions +26 to +40, was used to 
sequence all rabbit p-globin expression vectors.
3'-AT GAACGTTAGGGGG-5'
4 .6  Preparation of 5'-32P-labeled S1 mapping probes.
In general, 15 pg of plasmid DNA was digested using the appropriate restriction enzyme 
as recommended by the suppliers after which 2 vol of 0.1 M Tris-HCI (pH 8.7) and 1 pi of calf 
intestinal alkaline phosphatase (Pharmacia; 5000-10000 units/ml) were added. Following 
incubation at 37 °C for 30 min, the enzyme was inactivated at 65 °C for 15 min. The 
supernatant was phenol/chloroform (1:1) extracted and the aqueous layer fractionated over 
a 1.5 ml Sephadex G-50/TNE column. Peak fractions were pooled, EtOH precipitated and 
the pellets obtained following centrifugation dissolved in 30-50 pi H2O. Recovery was 
determined by UV spectroscopy.
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Kinase reactions were carried out at 37 °C for 30 min in a solution containing 50 mM Tris- 
HCI (pH 9.5), 10 mM MgCl2, 5 mM DTT, 0.1 pg/ml dephosphorylated DNA, ~0.05 units/pl T4 
polynuclease kinase (K. Murray, University of Edinburgh) and a 5-10 fold molar excess of 
y-32p_ATP (6 pmol/pl at 5000-7000 Ci/mmol). The DNA was phenol/chloroform (1:1) 
extracted and the aqueous phase loaded onto a 1.5 ml Sephadex G-50/TNE column. Peak 
fractions were pooled, EtOH precipitated and subjected to a second restriction digestion 
using the appropriate restriction enzyme. The resulting fragments were separated on 1-2% 
low gelling agarose gels with standards were run in parallel to allow estimation of recovery. 
The desired fragments were excised, recovered from agarose (see Section 4.4) dissolved in 
80% FAHB (80% formamide, 400 mM NaCI, 40 mM Pipes (pH 6.4), 1 mM EDTA), such that 
the final concentrations were 0.01 pmol/10 pi 80% FAHB. Specific activities of probes 
ranged from 2-6x106 Cerenkov cpm/pmol
probe plasmid primary 
restriction digest
secondary 
restriction diaest
fragment
isolated
rabbit p-globin rpGA4 BamH Pstl 452 bp
CMV-7K PSTC407-556 BamHI Sad 167 bp
3' end Hu IFN-a1 SP6a l  3' EcoRI Rsal 360 bp 1
rpGA4 Weber et al.,(1981) 1 copurified with a 386 bp
pSTC407-556 Severne et al. (1988) non-hybridising fragment
SP6ocl 3’ Streuli, (1986)
4 .7  Synthesis of y-32p-ATP.
Prepared the following solutions;
Mix A Mix B
50 pi 500 mM Tris-HCI (pH 9) 50 pi Cysteine Solution (see below)
30 pi 100 mM DTT 10 pi H20
25 pi 2.4 mM L-a-glycerol phosphate 7 pi 500 mM Tris-HCI (pH 9)
25 pi 10 mM p-NAD 5 pi Enzyme Solution (see below)
20 pi 300 mM MgCl2
12.5 pi 2 mM Na-ADP Cvsteine Solution
12.5 pi 40 mM Na-pyruvate
Dissolved 47 mg cysteine in 5 ml 
H2O into which was dissolve 70 mg 
of Trizma base.
Enzvme Mix
100 pi Glycine-3-phosphate dehydrogenase (2 mg/ml; Boehringer)
1 pi Triosephosphate isomerase (2 mg/ml; Boehringer)
20 pi Glycerinaldehyde-3 phosphate dehydrogenase (10 mg/ml; Boehringer)
2 pi 3-phosphoglycerate kinase (10 mg/ml; Boehringer)
20 pi Lactate dehydrogenase (5 mg/ml; Boehringer)
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Resuspended the Enzyme Mix by inverting the tube a few times. Removed 15 pi, 
transferred to a fresh tube, spun 3 min, sucked off the supernatant and dissolved the pellet 
in 15 pi of 50 mM Tris-HCI (pH 9), to generate the Enzvme Solution.
Synthesis Reaction
To 60 pi 32P-orthophosphate (15 mCi; Amersham) added 32 pi Mix A and 8 pi Mix B, 
vortexed gently and incubated at room temperature for 1 hr (incorporation usually >80%). 
Added 100 pi H2O, phenol/chloroform extracted once (1:1), ether extracted twice, diluted 
the aqueous phase to ~40-50 pCi/pl in 5 mM DTT, prepared aliquotes and stored -20 °C.
4 .8  Cell culture and DNA transfections.
4.8.1 HeLa cells.
HeLa cells were maintained in Iscov's medium (Gibco) supplemented with 5% fetal calf
serum (FCS) at 37°C in an atmosphere of 5% CO2 . For transfection 1.5-2x105 cells were 
seeded in a 60-cm dish. After 18-24 hr, 10 pg plasmid DNA (in 120 pi H20 ) and 120 pi
4x Ca-Hepes were mixed by tapping and then incubated 5' at room temperature. Following 
the addition of 240 pi 2x Hepes-phosphate the DNA solution was incubated for an additional 
15 min at room temperature, pipetted onto the cells and incubated for 12 hr at 37 °C. The 
medium was removed, cells washed with PBS (0.8% NaCI, 0.1% KCI, 0.72% Na2HP0 4 ,
0.1% KH2PO 4), fresh medium added and the plates returned to the incubator for an 
additional 36 hr.
4x,Qa:Hgpes
10 ml 0.5 M Hepes 1
12.5 ml 2MCaCl2
27.5 ml H20
2x Hepes-phosphate
10 ml 0.5 M Hepes 1
10 ml 2.8 M NaCI
80 ml H2O
300 pi 0.5 M NaPi 2
1 = (10 ml 0.5M Hepes pH 6.5 + 2.5 ml 0.5M Hepes pH 7.3)
2 = (50 ml 0.5 M NaH2P04  + 50 ml 0.5 M Na2HP04 ); added after autoclaving the other
components.
4 . 8 .2  L929 cells.
Murine L929 cells were grown in DMEM medium (Gibco) supplemented with 5% FCS in a 
37 °C, 5% CO2 incubator. For transfection (2.8x106) cells were seeded in a 10-cm dish. 
After 18-24 hr they were washed once with TBS (Fujita et al., 1986) and 7 pg of each test 
and reference plasmid, and 7 pg of either the IRF-1 expression plasmid, pIRF-L ('with IRF-T) 
or the corresponding 'empty' expression vector CDM8 ('no IRF') in 1.12 ml of 0.5 mg/ml 
DEAE Dextran (in TBS) were added. After 30 min at room temperature the cells were
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shocked by adding 1 vol of 20% dimethylsulfoxid (DMSO) in TBS for 60 sec, rinsed twice 
with TBS and incubated at 37°C in DMEM/ 5% FCS for 48 hr.
4 . 8 . 3  Namalwa cells.
Namalwa (Human lymphoblastoid) cells were grown in suspension in RPMI-1640 medium 
(Gibco) supplemented with 10% FCS in an atmosphere of 5% CO2 at 37°C. Transfections 
were preformed in 15 ml Falcon tubes using 8x106 cells per transfection. The cells were 
pelleted at 1500 rpm for 5 min and washed twice with 8 ml TBS, after which the cells were 
gently resuspended in 600 jxl 0.5 mg/ml DEAE Dextran (in TBS) containing 2.5 pg test and 
2.5pg reference plasmid (30P; Kuhl et al., 1987). After 30 min at room temperature the cells 
were shocked by adding 1 vol of 12.5% DMSO in TBS for 3 min, rinsed twice with TBS, 
returned to 10-cm dishes and incubated at 37°C in RPMI-1640/10% FCS for 48 hr.
4 .9  Inductions.
48 hr after the completion of transfections cell were either NDV, IFN or mock induced. 
Induction was with 1000 units/ml of rat IFN-y (originating from H. Schellekens) or with NDV in 
serum-free medium (1.2 ml or 3.4 ml per 6-cm and 10-cm plate respectively of a dose 
previously determined to give maximal IFN production in L929 cells) for 1 hr, whereupon 9 ml 
of medium supplemented with FCS were added. Total RNA was prepared 8 hr after 
beginning of induction.
4 . 10  Isolation of RNA.
Cells were washed with PBS prior to being lysed with 5 ml of lysis buffer (6 M urea, 
3 M LiCI, 50 mM NaOAc, 200pg/ml heparin, 0.1% SDS). The lysate was homogenized twice 
for 1 min on ice at position 5 using a Sorvall omnimixer, transferred to 15 ml Corex tubes and
precipitated at 4°C overnight. The precipitate was collected at 10000 rpm, 25 min, 4 °C
(Sorvall HB4), washed with 5 ml washing buffer (8M urea, 4 M LiCI), air dried and dissolved in 
600 pi 200 mM NaOAc (pH 5), 0.2% SDS, 1 mM EDTA. The RNA was extracted with phenol, 
phenol/chloroform (1:1) and then chloroform and precipitated overnight with 2 vol EtOH. 
The RNA pellet was wash once with 80% EtOH, air dried, resuspended in 100-300 pi H2O 
and stored at -70 °C (for longer periods it was stored as an EtOH precipitate at -20 °C). RNA 
concentrations were determined spectrophotometrically.
4.11 S1 Mapping.
Lyophilized RNA (50 pg), was dissolved in 20pl 80% FAHB buffer containing 0.01 pmol 
of probe, over laid with a drop of paraffin oil, denatured at 65 °C for 15 min and hybridized at 
49 °C overnight (usually 12-16 hr). Globin standard RNA was either reticulocyte poly(A)+ 
RNA titrated as described in Ryals et al. (1985) or rabbit globin RNA (BRL) of which 50% was
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assumed to be p-globin (Morrison et al., 1974), in all cases 50 pg of yeast carrier was added 
and the standards were treated as the test RNA.
S1 digestion was done by adding 250 pi S1 Buffer (250 mM NaCI, 30 mM NaOAc (pH 
4.5), 1 mM ZnS04 , 20 pg/ml alkali-denatured carrier DNA) which contained 400 units/ml S1 
(Pharmacia) to the hybridization mixture and incubating at 30 °C for 90 min. The reaction was 
stopped by transferring the reaction mix to tubes containing 300 pi phenol/chloroform (1:1), 
samples were vortexed and placed on ice until all tubes had been processed. After 
centrifugation to separate the phases the aqueous layer was EtOH precipitated in the 
presence of 20 pg yeast carrier RNA, the resulting pellets were air dried and resuspended in 
8 pi formamide loading dye.
Samples were denatured in a boiling water bath for 1.5 min, transferred to ice and loaded 
directly onto a pre-run (2-4 hr) 40x28x0.1 cm, 6% acrylamide (20:1 cross-link), 7 M urea, 
50 mM TBE (50 mM Tris-base, 50 mM boric acid, 1 mM EDTA) gel. Gels were run at 1000- 
1200 volts until the xylene cyanol had reached the bottom. 32P-labeled fragments were 
visualized by autoradiography.
Radioactivity in test, reference, standard bands and blank areas was determined by 
Cerenkov counting. After background subtraction, uninduced and induced test signals 
were normalized to the cognate references signals and strands per cell were calculated 
using the following relationships:
1. Normalized test signal (cpm) T* = T x (YR) where T, test signal (cpm);
R R, reference signal (cpm).
where C, number of cells; b, radioactivity (cpm) 
recovered after S1 mapping 1 pg standard 
p-globin RNA (equivalent to 3x 106 strands).
4 . 12  Nuclear extracts.
Namalwa cells were grown in 0.5-3 liter spinner flasks to a density of ~1x106 cells/ml in 
RPMI-1640 containing 10% FCS at 37 °C. Nuclear extracts were prepared as described in 
Dignam et al. (1983) with minor modifications. After resuspending the nuclei, the 
supernatant was ammonium sulphate precipitated (0.33 g/ml) and resuspended in and 
dialysed against 20 mM Hepes (pH 7.9), 20% glycerol, 20 mM KCI, 2 mM MgCl2 , 0.2 mM 
EDTA, 0.5 mM DTT, 0.5 mM PMSF.
2 . strands/cell = T*.x 3„x1Q
C x b
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4 . 13  Preparation of probes for gel retardation assays.
1-3 pmol of single stranded oligonucleotide were 5'-32P-labeled in 10 pi containing 
50 mM Tris-HCI (pH 7.5), 6.6 mM MgCl2, 5 mM DTT, 1 mM spermidine, ~0.05 units/pl T4 
polynuclease kinase ( K. Murray, University of Edinburgh) and a 3-5 fold molar excess of 
y-32p-ATP (6 pmol/pl at 5000-7000 Ci/mmol) at 37 °C for 30 min. The reaction was stopped 
by the addition of 50 pi 10x TNE (which also improves the resolution of the column) and 
fractionated over a 1.5 ml Sephadex G25/H2O column eluted with H2O. Peak fractions were 
pooled and lyophilized.
The 5'-32P-labeled oligonucleotides were annealed to a threefold molar excess of their 
opposite strand in 10 pi 50 mM Tris-HCI (pH 7.5), 6.6 mM MgCl2,5 mM DTT, 1 mM 
spermidine. The mixture was heated to 85 °C for 10 min and then allowed to cool slowly to 
room temperature (> 3 hr). Probes prepared in such a way usually had a specificity activity of 
between 2 and 8x106 Cerenkov cpm/pmol.
Unlabeled oligonucleotides used in competition experiments were annealed in a similar 
manner except that equal amounts of both strands were used.
4 . 14  Gel retardation assays.
Crude nuclear extracts were used where not stated otherwise. Tenfold enriched TG 
protein (step I) was obtained by heating crude Namalwa nuclear extract at 85 °C for 5 min and 
removing the resulting precipitate by centrifugation, step II preparations were obtained by 
affinity chromatography (Kadonaga and Tjian, 1986) on immobilized VREal (A. Sailer and D. 
Maguire unpublished results). Binding reactions for the gel retardation assay (final volume, 
10 pi) contained 5'-32P-labeled oligonucleotide, non-specific and specific competitor DNA 
and nuclear extract as indicated in the figure legends. Incubations were done at room 
temperature for 30 min in 11 mM Hepes (pH 7.9), 45 mM KCI, 0.2 mM MgCl2 , 1 mM EDTA,
1 mM DTT, 4% Ficoll 400, 2% glycerol. After adding 2 pi of loading dye (4% Ficoll 400, 10 
mM Hepes (pH 7.9), 0.1% bromophenol blue) the samples were loaded onto a 20x20x0.1 
cm, 4% polyacrylamide gel (30:1 cross-link), 25 mM TBE (25 mM Tris-base, 25 mM boric acid, 
1.25 mM EDTA) gel, pre-run for 1 hr at 4 °C. Electrophoresis was for 2-2.5 hr at 4 °C, 250 
volts until the bromophenol blue was ~5 cm from the bottom of the gel. Gels were 
transferred to Whatman 3MM paper, fixed for 10 min in 10% acetic acid/5% methanol before 
being dried under vacuum at 60 °C for 1.5 hr. For quantitation, bands were cut from the dried 
gel.
4 . 15  Methylation interference analyses.
5'-32P-labeled oligonucleotides were partially methylated with dimethyl sulphate for 
between 4 and 8 min at room temperature (Siebenlist and Gilbert, 1980) and used as probes 
in scaled up gel retardation binding reaction (between 10 and 20 times). After
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electrophoretic separation over a conventional band shift gel (see Section 4.14) the DNA in 
the protein /DNA complex (retarded band) and the free DNA were excised from the 
polyacrylamide gel. The excised gel fragments were placed in 10 ml Greiner tubes, crushed 
with a glass rod and the DNA eluted overnight while agitating with 8 ml of 150 mM NaCI/TE 
(150 mM NaCI, 10 mM Tris-HCI (pH 8), 0.5 mM EDTA) at room temperature. The DNA was 
purified by DEAE cellulose (DE 52, Whatman) chromatography and EtOH precipitated.
Alkali cleavage (G>A reaction) was performed by dissolving the pellet in 20 pi of 10 mM 
NaP04  (pH 7), 1 mM EDTA, incubating 90 °C for 10 min, chilling on ice, adding 100 pi 
100 mM NaOH, 1 mM EDTA and continued to incubate at 90 °C for an additional 30 min. The 
pH was adjusted to 7 with 25 pi 1 M Tris-HCI (pH 7.5), 25 pi 2M NaOAc (pH 7), and 100 pi 
200 mM NaOAc (pH 4.7) and the DNA EtOH precipitated in the presence of 10 pg yeast 
carrier RNA. Pellets were resuspended in formamide loading dye and the products 
separated on 40x28x0.03 cm, 12-18% polyacrylamide (30:1 cross-link), 7 M urea, 
50 mM TBE gels.
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